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The intensely competitive nature of endurance sports drives athletes to 
great lengths in order to secure victory. When conditioning isn’t enough, athletes 
use artificial means of enhancing aerobic performance, despite being banned by 
anti-doping entities. As athletes develop new methods of blood doping, there 
invariably follow methods to detect their use. However, autologous blood 
transfusions (ABT), the removal and subsequent reinfusion of one’s own blood, 
remain the most difficult methods to detect. To mitigate its use, WADA 
introduced the Athlete Biological Passport (ABP). The ABP tracks an athlete’s 
long-term blood profile through numerous biomarkers; abnormal variations may 
be signs of doping, but are not definitive indicators, which necessitates a direct 
diagnostic technique. 
There is evidence that red blood cells (RBCs) undergo physiological 
changes in storage that are not mirrored in circulating RBCs. We explore methods 
to exploit storage-induced changes and develop a two-pronged assay to identify 
and separate reinfused RBCs from fresh cells. We probe the electrophoretic 
mobility of aging cells over 6 weeks using dielectrophoresis; this method yields 
visible separation of a 5% mixed blood population within seconds without labels 
or fluorescent tags. We investigate a microfluidic technique for high-throughput 
probing of RBC viscoelasticity. Using Real Time Deformability Cytometry 




 cells in seconds of high speed imaging; analysis 
 iii 
shows a clear decline in deformability. In simulated reinfusions, we see 
distinction between the fresh and the 5% reinfused population. As a direct 
detection method, this technique identifies blood doping in minutes with little 
sample preparation. As complementary parts of a single assay, DEP-RTDC tests 
can identify and isolate reinfused cells, increasing the efficacy of the ABP.  
 The need for sensitive detection is not limited to the world of elite athletic 
competitions, and is in growing demand in personalized medicine. We present a 
bead-based detection method, which provides a platform for numerous assays – 
whole blood tests and anti-doping assessments among them. By combining 
electrokinetics and microfluidics, we create a sensitive biosensor for detection at 
miscible, liquid-liquid interfaces. Arrays of microelectrodes embedded into 
microfluidic T-channels deliver AC electric fields directly into co-flowing 
laminar streams. Interfacial motion produced is a function of electrolyte 
properties and binding kinetics, and a metric for biomolecular detection. 
Integration of colloidal suspensions creates the capability of detecting biotin-
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Microfluidics and AC electrokinetics are used in this work in an attempt to 
satisfy a number of biosensing needs – namely sensitive, inexpensive, portable 
diagnostics for personal health, and the detection of autologous blood doping in 
endurance athletes.  
As athletes uncover and develop new methods of blood doping, there 
invariably follows a diagnostic method to detect its use. However, autologous 
blood transfusions (ABT), the removal and subsequent reinfusion of one’s own 
blood, remain one of the most difficult banned methods to detect. Current 
methods of detection, such as the multi-factor approach of the Athlete Biological 
Passport (ABP) are indirect and ultimately subjective; for this reason, we desire 
more direct, robust diagnostic techniques. We explore methods to investigate and 
exploit storage-induced changes and develop a two-pronged assay to identify 
reinfused red blood cells (RBCs) and separate this subpopulation from fresh cells. 







able to observe the deterioration of RBC electrical and mechanical properties over 
time, but we also show the detection of stored RBCs in an in vitro reinfusion as 
well as positive results for detection of blood doping in a round of in vivo ABT 
studies with competitive cyclists. 
Advances in portable biosensors are often bottlenecked at the transducing 
element, which thus far remains either expensive or bulky, deterring the ability to 
make the diagnostics truly portable or affordable for end-users. We describe in 
this work a novel biosensing platform that operates without expensive fluorescent 
tags and labels, with a trajectory toward being truly non-optical and portable. 
Utilizing microelectrodes embedded into microchannels, we combine 
microfluidics and electrokinetics to create a novel biosensor that operates at 
miscible, liquid-liquid interfaces with sensitive detection capabilities. The 
integration of a colloidal suspension creates a moving liquid substrate capable of 
detecting biotin-streptavidin binding at biotin concentrations as low as 500 
attomolar. This bead-based method provides a promising platform for a multitude 













 The following sections describe the electrokinetic phenomena 
dielectrophoresis, as it applies to both spherical particles, cells, and electrical 
liquid interfaces. This theory is utilized in later chapters to perform sensitive 
biodetection assays. 
 
2.1.1 Classical Dielectrophoresis 
 Classical dielectrophoresis (DEP) can be described as a phenomenon in 
which a non-uniform electric field induces charge on an otherwise uncharged 
particle and produces motion. The force exerted on an isotropic, spherical particle 
in a non-uniform AC electric field (E) can be described as
1
: 
          
               
 ,   (2.1) 
where a is the particle radius,    is the relative permittivity of the suspending 
medium, and          is the real part of the Claussius-Mossotti (CM) factor, 
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where each dielectric constant   is complex and a function of frequency1: 
      
 
  
      (2.3) 
It can be noted from Equation 2.3 that for low frequencies    , material 
conductivity     dominates the complex permittivity, and thus the polarization 
factor, called conductive polarization. At high frequencies, the conductive term 
becomes negligible, and the dielectric constant dominates relative polarizability, 
called dielectric polarization. There exists some mid-range frequency where these 
charging mechanisms are balanced, and the system crosses over from one 
mechanism to another. This “crossover” frequency        can be determined by 
setting Equation 2.2 equal to zero: 
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    (2.4) 
For positive values of the CM factor (Equation 2.2), particles are drawn to regions 
of high electric field strength, called positive dielectrophoresis (pDEP). When this 
factor is negative, particles will be repelled from these regions and instead be 
drawn to areas of low field strength, called negative dielectrophoresis (nDEP). 
Though systems may cross over from one charging mechanism to another, not all 







 Cellular DEP poses a slightly more complex problem, due to the existence 
of a cellular membrane. The presence this third regime introduces another 
complex permittivity, and the CM factor is instead described as
1
: 
     
    
    
 
    
     
       (2.5) 
where     
  is defined as the effective complex permittivity for a cell containing 
both cytoplasm and membrane regimes
1
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 This theory is utilized experimentally in Chapter 4 for dielectrophoretic 
detection of storage-induced electrical changes in red blood cells. 
 
2.1.2 Fluidic Dielectrophoresis 
 The theory of polarizable interfaces applied to particles can also be 
applied to a liquid-liquid interface. For two electrolytes co-flowing in a 
microfluidic channel, the DEP force can be described as
2
: 
                            
  .   (2.7) 
where the new CM factor and COF is terms of the complex permittivities of 
electrolyte streams 1 & 2: 
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 This theory is experimentally validated later in Chapters 7 & 8. 
 
2.2 Bead-Based Biosensors 
 The ability to detect biomolecular targets at low concentrations without 
labels is an important requirement in areas including clinical diagnostics, drug 
discovery, environmental monitoring, and biomedical research. To be successful, 
biosensors typically require three basic components – a substrate for specific 
binding to occur, a transducer to translate the binding event into a detectable 
signal, and a detector to measure the transduced signal.  
 
2.2.1 Static-Substrate Biosensors 
 Bead-based heterogeneous biosensors use nanoparticles with surface-
immobilized receptors as a biosensing substrate for detecting a wide range of 
biomolecular analyte targets including proteins
3
, DNA, and bacteria
4,5
. In 
comparison to traditional substrate-based microarray technology, the high 
surface-area-to-volume ratio of functionalized nanoparticles can lead to increased 
detection sensitivity and reduced assay time. Bead-based methods, for example, 





, and electrochemical amperic detection
8



















 Nanoparticle-based biosensing is often accomplished using a 
heterogeneous support, where particles are adsorbed onto a solid surface
12
 or a 
sol-gel matrix
13
. Nanoparticles functionalized with specific receptors are then 
flushed with a fluid or gas containing the relevant target analyte. Because colloids 
must be functionalized and assembled, current bead-based methods typically 
require multiple rinsing/drying steps
14,15
, can suffer from functional group 
crowding
16
 and surface fouling
17
, and are usually designed for single use. 
 
2.2.2 Liquid-Liquid Interfacial Biosensors 
 To reduce detection time and assay complexity, and to improve 
portability, biosensors can be integrated with microfluidics. With microfluidics, 
biomolecular binding can occur in solution phase at the interface formed between 
laminar liquid streams using low Reynolds number fluid flow. This sensing 
strategy is robust and has been successfully applied to detecting DNA 
hybridization
18
 and for protein immunoassays
19
.  
 Laminar liquid interfaces can be created using “T-channel” or “Y-
channel” microfluidic geometries
20,21
. The two fluids produce a quasi-stable liquid 
interface at their co-flowing contact region, where at low Reynolds number mass 









biosensing though diffusional mixing and biomolecular binding has several 
advantages over traditional heterogeneous biosensing at solid substrates. First, 
because biomolecular binding occurs in solution phase as opposed to a solid 
surface, diffusion-limited binding occurs over much shorter timescales. Second, 
the interfacial substrate is continually replenished and renewed at any given 
position in the microchannel and is therefore not subject to surface fouling and 
non-specific adsorption.  
 Despite the usefulness and advantages, current liquid interface-based 
microfluidic strategies require fluorescent labeling and fluorescent microscopy for 
signal transduction and detection
23
. By utilizing the fDEP theory outlined in 
Equations 2.7-2.9, we can use alternating current (AC) electric fields to polarize 
and electrically stress an electrolytic interface with a mismatch of electrical 
properties on either side. When an electric field is applied, charges accumulate 
and force the interface to deflect across a microfluidic channel. The magnitude 
and direction of this deflection is sensitive to the interfacial electrical properties
2
. 
Exploiting this phenomena, Mavrogiannis et al. demonstrated that interfacial 
biomolecular binding influences the liquid electrical conductivity and 
polarizability of the liquid interface, and that binding can be detected by 
quantifying the degree of interfacial deflection at varying positions down the 
microchannel
24
. In this way, binding is transduced as a change in the interfacial 











 In Chapter 8, we extend the usefulness of IET to that of nanoparticle bead-
based assays investigate the ability to detect biomolecular binding on the surface 
of functionalized colloids subjected to specific biomolecular binding events 













 The following sections describe, in detail, the methods and procedures 
used throughout the entirety of the experimental chapters. The methods in this 
chapter are a combination of manufacturers’ recipes and insights gleaned from 
countless rounds of trial and error and have been adapted over the years to suit the 
distinct fabrication needs of this work.  
 
3.1 Photomasks 
Several types of microelectrodes and numerous different systems of 
microchannels are used in the body of this work. The processes to create these 
features are lengthy and situation-dependent, but all microfabrication methods 
first require a photomask. Photomasks are created with computer-aided drafting 
software, AutoCAD. All lines must be joined and closed to produce masks. In the 







are drawn in the same layer, duplicate lines and zero-width points can be made 
redundant with the “OVERKILL” command, and the lines can then be 
successfully joined and closed. The 2D wireframe drawing is saved as a 2010 
“.dxf” file and converted to a Gerber “.gbr” file with licensed software, LinkCAD. 
This step is not required, but is recommended to avoid incurring conversion fees 
from photomask companies. Each layer in the .dxf file will produce a separate 
.gbr file; separate layers are helpful when creating positive and negative masks in 
the same AutoCAD drawing. 
 Gerber files are sent to the photomask company FineLine Imaging in 
Colorado Springs, Colorado. For minimum mask feature sizes smaller than 7 
microns, a chrome mask is required and FineLine Imaging cannot be used. For all 
other sizes, transparency masks are readily printable with pricing brackets 
corresponding to mask minimum feature sizes. All masks should be produced as 
5”x5” films; this size is well-suited for mounting on borosilicate glass or quartz 
used with the UV source and mask aligner.  
 Masks for microelectrodes are positive, or “clear field,” and are submitted 
to FineLine with “Image Orientation and Polarity” as “Clear Field, Right Read 
Down” (CFRRD). These masks are, in most cases, used with gold-covered 





Exceptions apply when a lift-off method, described in detail in section 3.2, is used 







negative, or “dark field” mask is created and submitted to FineLine as “Dark 
Field, Right Read Down” (DFRRD). Masks may also be submitted Right Read 
Up (CFRRU or DFRRU) if designs are symmetrical, but is not recommended, as 
texts and orientation-dependent designs will print reversed. 
Masks for microfluidic channels are negative, or dark field, and are 
submitted to FineLine as DFRRD. These masks are used with 4-inch, single side 
polished (SSP) silicon wafers and negative SU-8 epoxy photoresists (e.g. SU-8 
3000 series, SU-8 2100 series), and produce master molds with rectangular 
channel profiles, and are suitable for most microfluidic uses. Exceptions apply 





220 series); this requires a positive, or 
clear field, mask and is submitted to FineLine as CFRRD.  
 
3.2 Microelectrodes 
Some electrodes vary only in their design, and are fabricated using the 
same protocol. In Chapter 4, two sets of electrodes utilize the same design, but are 
composed of two different metallic makeups, and require entirely separate 
protocols. In this work, a quadrupole electrode array is used to create distinct 
regions of high and low electric field strength, for the purpose of tracking 
electrical behavior and separating particles and cells of interest. The electrode 







mirrored across a long axis, such that the arrays of points face each other, for the 
purpose of focusing the field at the interface of two laminar streams in a 
microfluidic device. Though they may differ in design and composition, all 
electrodes in this body of work deliver an electric field to samples or buffers of 
interest through direct contact. Contactless electrodes require different materials 
and fabrication procedures, which are neither used nor described in this work. 
 
3.2.1 Physical vapor deposition 
Electrodes used in this work are created top-down; layers are first built up 
through physical vapor deposition (PVD), then selectively removed to create the 
desired structures. PVD, is an umbrella term for several different vacuum-
facilitated deposition methods, including electron beam, evaporative, and 
sputtering PVD, which differ in how the target material is vaporized for 
subsequent deposition on the coverglass. In this work, we first clean glass 
coverslides (50x30 mm, no. 1, Fisher Scientific) in an acetone bath followed by 
an isopropyl alcohol (IPA) bath, followed by blow drying with dry nitrogen gas. 
Slides that have not been cleaned in this manner will exhibit poor adhesion to the 
following deposition layers, and may wipe or wash off. Using electron beam 
PVD, the slides are coated with a 20 nm layer of chromium, followed by a 30 nm 
layer of gold (Kurt J. Lesker Company). Chrome is inexpensive and bonds well to 







substituted for this layer in this case. The layer thickness described can be 
modulated without loss of electrical performance, though etching times may vary. 
Layers as thin as 10 nm chrome and 20 nm gold have been used in this work with 
no noticeable differences between devices. 
 
3.2.2 Photolithography 
Positive photoresist (S1813, Shipley) is spin-coated onto the gold-coated 
slides at 2000 rpm for 60 seconds, creating a 2 m layer of photoresist. The slides 
are rinsed with acetone and IPA, followed by a dehydration bake at 110-130°C 
for at least 10 minutes. If the slides have been stored, or if the atmosphere is 
humid, these cleaning steps are imperative. Dehydration temperature should not 
exceed 150°C – at this temperature the gold and chrome layers anneal together 
and do not etch well. Resist is baked for 2 minutes at 95°C before exposure to 
light source at 95 mJ/cm
2
. Exposure to light selectively crosslinks the photoresist; 
washing in a bath of developer (CD-26, Shipley) removes areas exposed to light, 
leaving a protective mask that resists etching. The slide is rinsed in DI water and 
carefully blown dry with dry nitrogen. The quality and integrity of the design in 
the photoresist is checked under a microscope – at this point, if the quality of the 
lithography is poor, the resist can be washed off with acetone and IPA and respun, 
exposed and developed; however, once the slide is etched, the design is 







away by the pressure of the drying nitrogen are indications of poor resist 
adhesion. If resist adhesion is still poor after care has been taken to clean and 
dehydrate the slide, hexamethyldisilazane (HMDS), an adhesion promoter, is spun 
onto the slide (though vapor deposition is preferred) prior to the resist, using the 
same spin recipe. Caution is exercised, and the spin-coater and slide is allowed to 
vent in the fume hood for several minutes prior to spin-coating the photoresist, as 
HDMS is corrosive and toxic, and should never make contact with skin or be 
inhaled. 
 
3.2.3 Wet etching 
The top layer of gold is etched first with an iodine-based gold etchant 
(Alfa Aesar). The gold layer etches in seconds and is visually evidenced by the 
dissolution of gold’s characteristic shine. Gold is easily over-etched and will 
undercut the resist layer and must be removed from the bath and immersed in a 
deionized (DI) water bath immediately upon completion of etching. The slide is 
then placed in a bath of chrome etchant (Alfa Aesar), which etches more slowly 
and does not as quickly undercut the gold layer. The glass slide can be removed 
when the background of the slide becomes transparent and be rinsed with DI 
water before washing with acetone and IPA. Etching steps should be performed in 
either Teflon dishes or some other hydrophobic fluoropolymer dish, as 







leads are soldered to the electrode array with indium pellets (Sigma Aldrich); 
soldering on a hot plate set at its lowest temperature is recommended, as a 
standard lab bench top acts as a heat sink and makes soldering on thin coverglass 
difficult. For most work in Chapter 4, the prepared electrode array is ready to use. 
For select parts of Chapter 4, and for the entirety of Chapters 7 & 8, the electrodes 
must be paired with a microfluidic flow layer before use. 
 
3.2.4 Lift-off technique 
 Most work in Chapter 4 uses gold electrodes fabricated with the methods 
described above. Other experiments in this chapter utilize ITO electrodes, which 
are an attractive option due to the transparency of thin ITO films. ITO is readily 
deposited using electron beam PVD but requires either harsh proprietary etchants 
or 1 molar hydrogen chloride (1M HCl), both of which are strong acids and 
regularly undercut resist and destroy the integrity of designs and are difficult to 
dispose of – trace amounts of ITO etchant in DI water stain the water bath and the 
laboratory sink and may damage baths and sinks that are not HCl compatible. 
Etching quality is enhanced on purchased, pre-coated ITO glass slides, but are 
limited to predetermined slide thicknesses which are not suited for high-objective 
imaging. A lift-off method is more desirable for both safety and expenses. 
 Lift-off is a top-down fabrication technique requiring a sacrificial layer to 







negative resists can be used to perform lift-off with the appropriate coordination 
of mask polarity – a positive resist used with a negative mask, and a negative 
resist used with a positive mask. In this work, positive resists S1813 is used with a 
negative photomask, and the resists is spun, baked, exposed, and developed in the 
same manner as the standard gold etch method. After the design is inspected, the 
slide undergoes electron beam PVD to deposit ITO to a thickness of 180 nm. The 
ITO-coated slides are washed in an acetone bath to dissolve the photoresist and 
remove the ITO from the masked areas. A staining jar with an acetone-resistant 
lid is preferable for this step; flat dish baths may dissolve the resist and allow the 
ITO to settle onto the glass surface, where it becomes difficult to remove without 
damaging the electrode design. The ITO electrodes then undergo an annealing 
step on a hot plate for 2 hours at 500°C – this process transforms the ITO into a 
transparent conductive film
25,26
. After 2 hours, the hot plate is turned off and the 
transparent slides are left to cool on the hot plate; premature removal of slides 
from the hot plate can cause thermal shock and break the thin coverglass. 
 The resulting ITO electrodes do not bond to indium solder, and an 
additional chrome deposition step is added – the slide is masked with paper and 
tape such that chrome deposits only on the four corners of the slide, overlapping 
the ITO in those areas. Electrical leads can then be readily soldered to the 







leads directly on the ITO, though soldering is a more permanent method and is 
preferred. 
 
3.2 Microchannel fabrication 
Microfluidic flow channels are utilized extensively in this work. The soft 
lithography process used to create them is not unlike the photolithography process 
used to create the microelectrode arrays that end up embedded in many of the 
channels. 
 
3.2.1 Soft lithography 
 To fabricate the microchannel, we instead begin with a 4-inch SSP silicon 
wafer (University Wafer), washed with IPA and dehydration baked at 200°C for 
at least 30 minutes. The wafer is centered on the spin-coater and the alignment 
checked by briefly spinning the wafer and adjusting the position if necessary. For 
most flow channels in this work, a rectangular channel cross section is desired. 
The appropriate SU-8 series of epoxy-based, negative photoresist for the desired 
channel height is used and spin-coated onto the wafer according to the 
manufacturer’s datasheet. Soft bake times, exposure energies to be used with a 
negative photomask, post exposure bake times, and development times vary for 
each recipe, and should be followed according to the appropriate datasheet. The 







turned off and the wafer allowed to cool on the hot plate. Premature removal of 
the hot wafer can cause thermal shock and crack the epoxy design. 
 The cooled wafer is a master mold from which as many microchannels can 
be cast until the design degrades or the wafer breaks. The channels are cast by 
pouring a silicone-based polymer, polydimethylsiloxane (PDMS), over the wafer 
in a round-base weigh boat. For most uses, PDMS is mixed in a 10:1 elastomer-
to-curing-agent ratio, though the stiffness of the resulting polymer can be 
modulated by varying the ratio. In most cases, PDMS is asymmetrically mixed in 
a planetary mixer (Thinky USA), which effectively mixes PDMS volumes 
weighing up to 55g. Heavier quantities will break the bottom of the mixing cup 
and spill the PDMS into the mixer, and thus must be mixed thoroughly by hand 
with a glass stir rod. The wafer is left at room temperature for at least 15 minutes 
before baking at 85°C for 15-30 minutes. At least 15 minutes is required to allow 
microbubbles created from pouring the PDMS to absorb into the bulk, even when 
there appear to be no microbubbles. Premature heat-curing of the polymer 
immobilizes air bubbles within the polymer – these bubbles are most often over 
the fluid ports and typically cause leaks at the inlet and outlet of the device. 
Alternatively, the wafer can be left at room temperature overnight with a final 
curing at 85°C for 10-15 minutes. Hand-mixed PDMS must be cured overnight at 
room temperature to absorb and disperse the air introduced while mixing. Once 







created with 0.75 mm biopsy punch (Ted Pella, Inc.). PDMS consumption can be 
reduced by 50-75% by removing only the PDMS around the microchannels with a 
razorblade, leaving the outlining regions on the wafer; the wafer subsequently 
requires only 10-25g of PDMS to recast the microchannels. 
 
3.2.2 Alignment and bonding devices 
The resulting microchannels are bonded to coverglass to seal the channels 
and allow fluid flow. In Chapter 5, microchannels are bonded to plain coverglass 
by exposure to oxygen plasma (Model 42A, Jetlight) for 1 minute, and 
immediately bringing the two pieces into contact to seal. In Chapters 7 & 8, 
electrodes must be embedded symmetrically along the length a long 
microchannel. The electrodes and PDMS are exposed to oxygen plasma for 1 
minute, and immediately aligned down the entire length of the microchannel by 
eye and hand under an inverted microscope, bringing the two pieces into contact 
to seal the channels, before baking overnight at 85°C. 
 
3.2.3 Multi-layer designs 
 Select work in Chapter 4 utilizes a microfluidic push-down valve system 
to quickly stop and start flow within the device. This design requires a multi-layer 
device, where a thin channel flows below a perpendicular channel dead-end filled 







pushes down and pinches off the bottom layer in the overlapping areas, stopping 
the flow. To effectively halt the main flow channel, the flow channel cross-section 
must be rounded, as opposed to rectangular. To achieve a rounded channel 
profile, positive photoresist SPR220 series is spun for a 15 m channel height and 
exposed with a positive photomask according to the manufacturer’s datasheet.  
The upper valve layer is fabricated with the previously described methods 
for rectangular channel profiles. The flow layer is cast in PDMS following the 
hard bake step; the PDMS of this layer must be thin and flexible, such that it 
creates a deformable membrane in the regions overlapping with the layer above. 
To facilitate peeling of a thin flexible layer, the wafer is silanized in a fume hood 
by placing the wafer and weigh boat in a vacuum desiccator and pipetting a few 
drops of trimethylchlorosilane (TMCS) on the wafer surface. The desiccator is 
closed and vacuumed for 1 minute before closing the vacuum valve and allowing 
the wafer to sit under vacuum in the silane gas for 1 hour. The wafer is then spin-
coated with PDMS mixed in a ratio of 20:1 to a total thickness of 30-40 m. The 
top layer is cast by pouring 45g of PDMS in a 10:1 ratio. Both wafers are cured 
overnight at room temperature, followed by a 15-minute bake at 85°C. The top 
layer is peeled off – if the multi-layer design requires tight control over alignment 
of the layers, it is often easier to cut and align each device on its own. In both 
cases, inlets are punched in the valve layer with a 0.75 mm biopsy punch. The 







an inverted microscope, and the top valve layer is aligned by hand and placed 
onto the bottom layer. The wafer is baked again with both layers at 85°C 
overnight. The two layers can then be easily peeled from the wafer, and the flow 
layer inlet and outlet at created with a 0.75 mm biopsy punch. The multi-layer 
assembly can then be exposed to oxygen plasma, aligned and bonded onto a 
quadrupole electrode array and baked overnight.  
  
3.3 Blood sample preparation 
The following sections describe the methods used to draw, store, and 
prepare blood samples for studies in this work. Chapters 4 & 5 use blood sourced 
from vendors, volunteered from graduate students, and volunteered from 
competitive cyclists. All human blood in this body of work is of male origin. All 
studies were performed with the Homewood Institutional Review Board (HIRB) 
approval, and with proper blood borne pathogen laboratory safety training and 
certification. All mammalian blood is handled in a biological safety cabinet 
designated exclusively for use with mammalian cells, and all biological waste is 
bleached prior to disposal. All solutions are made with 18 MΩ deionized water. 
 
3.3.1 Blood sourcing, drawing, and storage 
 Blood was purchased from both non-human mammalian (Quad Five) and 







body of work as “animal”) blood was obtained from equine (horse), 
caprine/hircine (goat), ovine (sheep), and bovine (cow) sources with a citrate 
anticoagulant additive. Human blood vendors provided anonymous datasheets of 
donor sex, age, blood type, ethnicity, etc. with each sample containing a citrate 
phosphate dextrose (CPD) anticoagulant additive. Both animal and human blood 
sourced from vendors were divided into 0.5-1.0 mL aliquots upon arrival. 
 For student volunteers, only male graduate students within the Department 
of Chemical and Biomolecular Engineering were considered. Modest monetary 
compensation was offered at $10 per blood draw session, with a $30 bonus for 
completing all scheduled draws. All participants were given an HIRB-approved 
outline of the study and informed consent form. Volunteers signed and 
participated of their own free will; electronic and print copies of their signed 
consent forms are retained for laboratory records, along with a confidential 
identity key – in this manner, all data identifiers remain anonymous for 
publications. Five students were selected based on their availabilities and 
willingness to complete the full schedule of blood draws.  
 Finger prick blood samples were drawn from volunteers with fingertip 
lancets (Owen Mumford) and allowed to pool on the fingertip. In most cases, 
optimum blood draw was facilitated by physically massaging more blood down 
the hand and into the finger. On cold days, two finger pricks were often 







draw; however, all volunteers readily offered multiple draws per session with no 
comments or complaints of discomfort. The volume of blood was quantified by 
drawing up the drop with a micropipette, and then stored in CPD in a ratio of 1:8 
anticoagulant-to-whole-blood. Typical finger prick blood draws ranged from 50-
100 L. One sample was collected per week for a duration of 7 weeks. All blood 
samples and aliquots are stored at 4 °C in a blood bank refrigerator (Jewett). 




 All blood samples require washing steps to isolate the red blood cells 
(RBCs) for experiments. Centrifugation of whole blood separates the blood 
components by weight, with red blood cells gathering as a pellet at the bottom. 
Three washing cycles are necessary to ensure complete removal of all other 
components. At the appropriate time point, the required volume is removed from 
a new aliquot and added to a microcentrifuge vial with 1.0 mL of isotonic 
phosphate buffered saline (1X PBS). The dilution is centrifuged at 2000 relative 
centrifugal force (rcf) for 2 minutes, the supernatant removed and replaced with 
fresh 1X PBS, and vortexed to mix the fresh suspension. Care is taken when 







use, as inattention can cause cross-contamination of samples and contamination of 
stock solutions. 
In Chapter 5, the third removal is followed by resuspension in a solution 
of 1X PBS containing 0.5% (w/v) methylcellulose (mc). Methylcellulose is added 
to increase the viscosity of the buffer and prolong the suspension of RBCs in 
solution. The resuspension volume must achieve a ratio of 1:50 whole-blood-to-
final-volume for the studies outlined in Chapter 5. Methylcellulose does not 
readily dissolve in aqueous solutions and requires agitation with a magnetic stir 
bar at high revolutions for several hours, preferably overnight. The solution is 
easily aerated upon shaking and must rest before use. Methylcellulose solutions 
are passed through a 0.2 m filter before every use, which effectively prevents 
clogging in microchannels for the duration of the experiments. Microfluidic 
devices used with methylcellulose are single-use; attempting to flush and reuse a 
device typically leads to clogging within minutes.  
 
3.3.3 Glutaraldehyde fixation 
 In Chapter 4, the third removal of the supernatant from the RBC washing 
steps is followed by resuspension in a solution of 1X PBS. 25% (w/v) stock 
glutaraldehyde (glt) is added to this suspension in appropriate volumes to yield an 
overall concentration of 0.15-2.5% (w/v) glt. Glutaraldehyde crosslinks the 







addition to the suspension. The samples are placed in a vial rack, covered tightly 
with tape, and placed on a shaker at room temperature to fix for 1 hour under 
gentle agitation. The fixed samples are then washed three times with 1X at 6500 
rcf for 5 minutes. During post-fixation washing steps, cells pellet densely at the 
bottom of the vial and may not completely resuspend by vortexing – in this case, 
the bottom of the vial can be gently flicked several times with a finger to dislodge 
the pellet, and vortexed to resuspend. Following the 1X PBS washing steps, the 
fixed cells are washed again with the experimental buffer, a zwitterion solution of 
0.8-3M 6-aminohexanoic acid (AHA) (Sigma Aldrich). The cells are washed and 
resuspended one last time in the experimental buffer before use. 
 
3.4 Flow sources 
 Flow is driven through microchannels by a number of methods. This work 
utilizes the following three methods with varying degrees of success. In each 
chapter containing experimental work, a different degree of fluid flow control is 
required to adequately and precisely control the experimental parameters, and a 









3.4.1 Syringe pump 
 Syringe pumps are often microfluidic flow sources and are well-suited as a 
flow source in Chapter 5. This work requires simultaneous control of two flow 
rates, which must remain identical. A more sophisticated, automated flow 
controller can be used here, although it is not necessary. A syringe pump is not 
desirable for the work in Chapter 4, as halting the flow driven by a syringe pump 
rapidly increases the internal pressure of the microfluidic device and invariably 
leads to device rupture. There is use for a syringe pump in the work outlined in 
Chapter 5, though independent flow rate control over two streams is desired, and 
thus requires either two syringe pumps or a combination of flow sources. A 
syringe pump is insufficient for the work described in Chapters 7 & 8, where a 
steady, position-dependent interface must be maintained. The pulsatile nature of 
the syringe pump flow creates a visibly oscillatory interface, which makes data 
measurements difficult. 
 
3.4.2 Automated flow controller 
 The automated flow controller in this work is an OB1 mk3 model 
purchased from ELVESYS. The costs of flow controllers of this caliber routinely 
exceed $20,000 USD and require proprietary accessories to facilitate sample 
delivery to devices. When paired with propriety flowrate sensors and software, a 







through automated pressure regulation; in this manner, flow can be delivered as 
either constant pressure or constant flow rate. This is a desirable option for 
experiments with long run times; if a feedback loop is not engaged, depletion of 
sample volumes lowers the hydrostatic head and produces a decreasing flowrate 
over time for a constant pressure source. This system is sophisticated, requires 
little user input or intervention, and meets most microfluidic needs. However, 
through experience and time, the work in Chapters 7 & 8 favors use of our manual 
flow controller described in the next section over the automated black box 
controller. 
 
3.4.3 Constant pressure manual flow controller 
3.4.3.1 A low-cost microfluidic flow controller  
Our microfluidic flow controller drives fluid flow through microfluidic 
channels using a constant pressure source. Unlike commercial solutions, the entire 
system uses readily available plastic fittings, costs $500 USD and requires less 
than 1 hour to assemble. The system, illustrated in Fig 1, is capable of delivering 
flow to four independently addressable microfluidic channel inputs at a fraction of 
the cost of a single syringe pump. Pressurized house air (~50 psi) powers the flow 
controller. As shown in Figure 3.1, blue airline tubing exits a pressure regulator 
and is split into four separate lines (labeled 1, 2, 3, and 4) using an aluminum 







line. When each switch is turned, pressurized air is sent into a precision pressure 
regulator, which controls the output pressure and directs this into a fluid-filled 
cryogenic sample vial. The pressure inside the vial increases and drives fluid flow 
through the tubing and the microfluidic device. We control the flow rate by 
adjusting this pressure using the precision pressure regulator and monitoring the 
air pressure on the accompanying pressure gauge. 
 
3.4.3.2 Hydraulic circuit analysis 
To regulate the fluid flow rate and render it independent to varying device 
geometry, we place hydraulic resistors upstream of the microfluidic device. The 
resistors are short lengths of capillary tubing and have a much larger 
hydrodynamic resistance than the downstream microfluidic device. 
 
Figure 3.1. (a) Low-cost microfluidic flow controller for controlling flows through four fluidic 
inlets. (b) Schematic of pressurized sample vial. A pressure (Po) is applied to a cryovial and fluid 







and exiting through outlet tubing (R3) at a flow rate Q. (c) Hydraulic circuit diagram of the fluidic 
system. 
In this way, fluid flow through the micro device is dictated by the 
resistance of the upstream hydraulic resistor and not the microfluidic device. 
These hydraulic resistors are a useful feature of this system because changes in 
device design will not influence the pressure-flow relationship within the 
microfluidic chip. Therefore, the user only needs to measure the pressure-flow 
rate relationship once, and it will remain accurate for devices of related, but 
different geometry. 
Constant pressure sources can be reliably engineered to produce well-
controlled flows in microfluidic systems using hydraulic circuit analysis. This 
method treats a network of microchannels as a complex circuit of fluidic resistors. 
For low Reynolds number flow in microchannels, there is an approximately linear 
relationship between pressure and flow rate. For an infinitely long cylindrical 
microchannel with a uniform circular cross section area, A, channel radius R, 
aligned in the positive z-direction, the fluid velocity profile at any given radial 
point r in the channel cross-section is given by 





            (1) 
where   and       are the fluid viscosity and axial channel pressure gradient, 
respectively. To calculate the flow rate, the fluid velocity profile can be integrated 







   




 .     (2) 
Assuming the channel length (L) is much larger than the channel radius (R), we 
can neglect entrance effects and treat each channel as an infinitely long tube. 
Replacing dP/dx with     , where            , is the pressure drop across 
the channel (e.g., the difference between the pressure at the inlet and the outlet), 
we can write this relationship between pressure and flow rate as 
  
     
   
 ,     (3) 
which is known as the Hagen-Poiseuille law. Based on Eq. (3), an applied 
pressure drop produces a flow rate Q that is proportional to the channel’s 
hydraulic resistance (Rh):         . The Hagen-Poiseuille law describes to a 
good approximation the relationship between applied pressure and flow rate. It is 
analogous to Ohm’s law for electrical circuits, where the voltage (pressure) is 
proportional to the current (flow rate) 
       .      (4) 
This equation provides a good estimate for steady flow through long and narrow 
cylindrical microchannels, however, this relation can be extended to other channel 
shapes by replacing R with the hydraulic radius,        , where A and P are 
the channel cross-sectional area and perimeter, respectively. Using Eq. (3), we 
can design hydraulic resistors that serve as a bottle-neck for regulating flow rate 








3.4.3.3 Regulating flow rate 
We used hydraulic circuit analysis to design fluidic resistor elements that 
can predictably restrict the flow rate through an arbitrary microfluidic device. To 
generate microfluidic flow, we apply a known air pressure (Po) to a sealed fluid-
filled vial and maintain the device outlet at 1 atm (P1), as depicted in Figure 
3.1(b). Each flow line has five fluidic circuit components that influence the flow 
rate in a microfluidic device (Figure 3.1(c)). When the flow controller delivers a 
pressure, Po, to the sample vial, the pressure drives fluid flow into the submerged 
tubing and into the microfluidic device. 
One way to control fluid flow to the microfluidic chip is to insert flow 
elements with a large hydraulic resistance such that it dominates the pressure-flow 
rate behavior of the entire fluidic circuit. Illustrated in Figure 3.1(c), fluid will 
flow through five hydraulic resistors — the submerged inlet tubing (R1), the 
capillary resistor (Rcap), tubing at the microfluidic inlet (R2), the microfluidic 
device (Rchip), and the outlet tubing (R3). Modifications to any of these 
components directly influence the overall resistance of the entire fluidic circuit 
and resulting pressure-flow rate relationship. To design capillary circuit elements 
with sufficiently large enough hydraulic resistance to regulate flow, but not too 
large that flow is impeded, we measure the resistance of the microfluidic device 







                  If the capillary tubing has a resistance significantly 
larger than the remaining elements in the hydraulic circuit, it will serve as a 
predictable bottle-neck for regulating fluid flow rate. 
 
3.4.3.4 Flow controller assembly and testing method 
Here, we describe the assembly and operation of our microfluidic flow 
controller and the design of hydraulic resistors for flow rate regulation.  
 
3.4.3.4.1 Essential components 
Construction of the flow controller takes less than 1h and requires three 
primary assemblies: a pressure manifold, a multi-line manifold, and a sample 
holder. The entire system is powered by pressurized air and uses a series of 
pressure regulators, pneumatic air switches, and manifolds to control gas pressure 
inside sealed liquid-filled cryotubes and direct flow to microfluidic channels. To 
regulate the air pressure, we direct house gas (50 psi) through an air filter and into 
a primary pressure regulator (SMC Pneumatics, IR2010-NO2), where it exits at a 
fixed pressure (20psi). We use a pressure manifold with one inlet and four outputs 
(McMaster-Carr, 5469K121) to deliver this regulated air pressure to four separate 
fluid-filled cryovials. Each manifold output is fitted with a 3-way air switch 
(Pneumadyne, C030621) to control the gas flow to downstream precision pressure 







precision regulators control the gas pressure delivered to each cryovial, and the 
corresponding pressure gauges provide an easy way to monitor regulator pressure. 
Each of the airlines then connect to a multi-line manifold, which holds fluid-filled 
cryotubes for sample holding and pressure-driven fluid delivery to the 
microfluidic device. To deliver flow, we use a precision regulator to increase the 
air pressure inside a desired cryovial, which then forces flow through the 
submerged tubing and out into the chip. We can control the flow rate in each 
sealed vial by increasing or decreasing the vial pressure using the appropriate 
precision pressure regulator. 
 
3.4.3.4.2 Flow controller assembly 
To make this system easy to setup and operate, we attached the pressure 
manifolds, air regulators, and gauges to an inexpensive wooden pegboard using 
plastic cable ties. Before assembly, all threaded fittings were wrapped with two 
layers of Teflon tape to ensure a proper seal and prevent gas leaks. All 
components were fitted with push-to-connect fittings and connected with 1/4” 
PTFE tubing. The pressure manifold inline/outline was fit- ted 1/4–1/8 National 
Pipe Thread (NPT) male fittings (McMaster-Carr, 5779K108), and each gas outlet 
threaded to 3-way switches (Pneumadyne, C030621) with 1/4-10-32 UNF male 
connectors (McMaster Carr, 5779K246). Each switch controlled the airflow 







connectors. Regulator outlets were attached to pressure gauges (0–15 psi, 
McMaster-Carr, 3846K411) threaded into 1/8” brass T’s with 1/8” NPT male 
fittings. 
 
3.4.3.4.3 Sample holder assembly 
We used sealed cryovials as inexpensive and readily available pressure 
vessels for delivering fluid flow to microfluidic channels. The cryovial assembly 
houses the necessary components to load the fluid samples and to pressurize and 
direct their flow. Tubing from the outlet of each pressure gauge was connected to 
the back end of a multi-line manifold with 1/8” NPT connections and we 
connected male luer-lock fittings (7/16” hex–1/8-27 NPT, Value Plastics) to the 
front of the manifold. To attach a sealed vial to each of these fittings, we modified 
the top cap of each cryovial by drilling a small 3 mm diameter hole in the cap of 
each cryotube and attaching it to a plastic male luer fitting (7/1600 hex–1/8-27 
NPT, Value Plastics) using quick setting epoxy. After allowing the epoxy to cure 
for 15 min, we fitted the cap with the bottom of a male luer tee fitting. 
 
3.4.3.4.4 Connecting the tubing 
The final step in completing the sample assembly is to create an airtight 
connection that allows for the sample to flow from the pressurized cryotube, 







use of a female luer lug tee fitting. This inexpensive fitting has two openings and 
a third centered and oriented perpendicular to each opening. We attached the 
cryovial to the bottom opening of the tee fitting. At the top opening, we pushed 
plastic tubing (Cole Palmer), through a fitted male lock ring (Value Plastics), 
leaving 4” of exposed tubing within the cryovial. Epoxy was applied to the 
junction of the lock ring and tubing to make an airtight seal. The other end of the 
tubing is connected to a specific microfluidic device inlet. When pressurized, the 
fluid inside the vial will be driven into the tubing and the microfluidic device. 
 
3.4.4 Supplementary materials 
 
3.4.4.1 Hydraulic resistance measurements 
 We first used the flow controller to drive fluid flow at different applied 
pressures through microchannels of varying length. As shown in Figure 3.2, the 
flow rate was measured through microchannels 0.5, 1 and 1.5 cm in length and 
plotted as a function of applied pressure. All flow rate measurements were 
performed with microfluidic flow sensors (Elveflow MFS 2 and MFS 3). As 
expected and depicted in Figure 3.2(a), the Q-P relationship for each channel is 
significantly influenced by channel length and the slope of each dataset was used 
to determine each channel’s experimental hydraulic resistance. Using Eq. (3), we 







resistance of the longest microchannel by a factor of 10. We then repeated these 
experiments with this length of capillary tubing (15.5 cm) inserted upstream the 
inlet of each microfluidic channel. Since the capillary tube had the largest 
hydraulic resistance in the system, the flow rate for the system was dictated by the 
capillary tube, therefore, the flow rate was seen to be largely independent of the 
channel length (Figure 3.2(b)). 
 
3.4.4.2 Flow rate capabilities, stability and response time 
To demonstrate our system is a feasible low-cost alternative to commercial 
syringe pumps, we performed real-time flow response comparisons between the 
flow controller and a commercial syringe pump. Using a passive in-line flow 
sensor, flow rates were measured for both the flow controller and syringe pump in 
response to a step change in pressure. A time-response and stability comparison 
between the syringe pump and flow controller is shown in Figure 3.3(a). As 
illustrated, the flow controller has a significantly faster response time than the 
syringe pump, requiring less than 5 s to switch from a flow rate of 3 µL/min to 6 
µL/min. The syringe pump, however, took upwards of 60 s to reach steady state. 
The flow rate stability is approximately the same for both the syringe pump and 
flow controller with an approximate 0.2 µL/min variation. The syringe pump, 
however, becomes pulsatile and unstable at a low flow rate (1 µL/min), shown in 







pump, one can see the syringe pump produced a pulsatile flow, while under the 
same conditions the flow controller produced a constant flow. Finally, it is 
important to note the operating range of the flow rates produced by the flow 
controller. We found the flow controller can provide reliable and steady flow rates 
from 0.5 to 35 µL/min with a 15.5 cm long capillary resistor. However, the user 
can alter this range by adjusting the length of the upstream capillary tubing. A 
longer capillary, for example, will produce a smaller flow rate, while a shorter 
capillary tube will allow for increased flow rate. 
 
Figure 3.2. (a) Pressure versus flow rate for three channel lengths without a capillary tube. (b) 
Pressure versus flow rate for three channels with an upstream capillary resistor and with a 










Figure 3.3. (a) Time response comparison of the presented flow controller and a commercial 
syringe pump. The syringe pump requires, on average, 20 s to stabilize while the flow controller 
requires less than five seconds. In some instances, the syringe pump requires almost 60 s, as 
shown in the subplot. (b) Flow rate comparison between the flow controller and syringe pump at 1 
µL/min. The syringe pump exhibits pulsatile flow at low flow rates while the flow controller 
offers stable flow rates. 
 
3.4.4.3 Flow switches prevent fluid back flow 
For many microfluidic applications, it is not sufficient to simply control 
when a single flow stream is on or off. Experiments in cell biology, for example, 
often require the ability to vary the fluid flow rate and switch between multiple 
streams. To accommodate these requirements, we also developed a simple and 
inexpensive switching solution to make our flow system suitable for a broader 
range of microfluidic applications. This is an important feature because switching 
flows on and off using pressurized fluid vials can be initially challenging because 
fluid flow follows the path of least resistance in a microfluidic network. It is 







from one fluid-filled vial flows into the device and then unwantedly flows back 
out into a neighboring vial. 
Backflow occurs when a pressure difference between two microfluidic 
inlets exist that is large enough to drive flow from one inlet, into the device, and 
out into a second inlet. Backflow is typically unwanted because it can 
contaminate neighboring vial samples and lead to longer setup times. To alleviate 
this problem, we designed a novel and inexpensive flow controller switch (Figure 
3.4(a)) to prevent backflow. 
To test the effectiveness of the flow controller switch, we used a 
microfluidic T-channel device with two inlets and one single outlet, shown in 
Figure 3.4(b). Two fluid streams were driven into the device at equal pressures to 
produce co-laminar streams that flow side-by-side. To aid in flow visualization, 
one fluid stream was dyed with Alexa Fluor 488 (green) and the adjacent stream 
is dyed with Alexa Fluor 594 (red). The applied pressures for both solutions were 
equal, producing a fluid interface centered in the main flow channel. Each fluid 
line was turned on or off using the appropriate flow controller switch. When the 
switch connected to the red solution was turned to the “off” position no backflow 
occurs (Figure 3.4(c)) Instead, the red solution stops in the T-channel junction. 
Conversely, when the red stream is turned “on” and the green stream turned “off,” 
the green stream stops before the junction (Figure 3.4(d)). While this is a simple 







single syringe pump. This tool is applicable to many applications including simple 
solution switching, chemical titrations, surface functionalization, and delivery of 
specific drugs, inhibitors or chemokines to downstream cells. 
 
Figure 3.4. (a) Low-cost fluidic switch for fluid routing. When the switch is turned “off,” it 
prevents the sample from flowing backward from one cryotube and into another. (b) Two laminar 
liquids flow side-by-side at equal flow rates in a microfluidic T-channel. (c) The switch for the 
“red” stream is turned off and the “green” stream follows the path of least resistance. (d) The 
switching is reversed. (e) Two samples with different cryotube volumes are delivered to a 
microfluidic T-channel. (f) Without a capillary the hydraulic head of the “green” stream is greater 
than the “red,” resulting in the “green” stream having a faster flow rate and the interface is not 
centered. (g) When the capillary is introduced to the same system both flow rates become equal 
and the interface becomes centered. The effect of the hydraulic head is eliminated as the flow rate 
is bottlenecked at the high resistive capillary. 
 
3.4.4.4 Flow contributions from hydrostatic pressure 
In addition to backflow, it is important to note that gravitational forces can 







we observed that when cryovial fluid volumes differed, a different pressure is 
required to produce equal flow rates. Because the sample volume exists over a 
height, h, several centimeters above the microfluidic device, a hydrostatic head 
pressure           exists between the top of the fluid sample and the base of 
the microfluidic chip. While this may appear trivial to the advanced microfluidics 
researcher, this feature is often overlooked by beginners and so we address how to 
solve this problem here. To observe this gravitational influence, we used a T-
channel device with a different fluid volume loaded in each cryovial, as shown in 
Figure 3.4(e). Each vial was filled with a different volume of DI water, one with a 
volume of 4 mL dyed with Alexa Fluor 488 (green) and the other with 1 mL and 
dyed with Alexa Fluor 561 (red). When equal pressure was applied to both 
cryovials, the liquid-liquid interface is not centered in the main channel, 
indicating that the flow rates in each fluid inlet are not equal. This occurs because 
the hydrostatic pressure is greater in one cryovial, and therefore, the overall 
pressure driving flow is also greater. Recall Eq. (4), flow rate is dependent on 
both the hydrodynamic resistance and pressure. The initial pressure has two 
components associated with its value, the applied pressure from the flow system 




   
  







For our flow controller with a sample volume 6 cm above the chip,      
0.1 psi, and is large enough to impact the fluid flow rate (Figure 3.4(f)). However, 
if the hydraulic circuit resistance is large relative to the chip, the gravitational 
contribution becomes negligible compared to the applied term (      0.1 psi) 
and we observe no gravitational impact on fluid flow. This is illustrated in Figure 
3.4(g), where a capillary was inserted upstream of each microfluidic inlet to 
produce perfectly centered liquid-liquid interface even when the sample volume 
heights were significantly different. 
With the ability to regulate and control the flow rate for microfluidic 
devices with varying hydraulic resistance, we now demonstrate the applicability 
of our flow controller to regulate chemical gradients to study cell migration and to 
generate microfluidic water-in-oil emulsions for droplet studies. 
 
 
Reprinted with permission from Biomicrofluidics
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 The ability to detect forms of blood doping is crucial in the fight for clean 
athletic competitions. In endurance athletes, the difference between victory and 
defeat often hinges on superior aerobic performance; this competitive ambition 
often drives athletes to employ various “banned methods,” as defined by the 
World Anti-Doping Agency (WADA) 
27
. As athletes uncover new methods of 
blood doping, there invariably follows a diagnostic method to detect its use
28-34
. 
Autologous blood transfusions (ABT), the removal and subsequent reinfusion of 








 In an effort to detect and mitigate its use, along with other banned 
methods, WADA introduced the Athlete Biological Passport (ABP) 
35,36
. The 
ABP tracks an athlete’s long term blood profile through a number of biomarkers; 
abnormal variations in this profile may be signs of blood doping, but are not 
definitive indicators of such
37
. Because the ABP in an indirect detection method 
and involves some amount of uncertainty, we desire a more direct, robust 
diagnostic technique. 
 Groups have turned to various methods to determine the presence of ABT, 
and to characterize the physiological changes RBCs experience in storage. There 
is evidence that red blood cells (RBCs) undergo physiological and biochemical 
changes in storage that are not mirrored in a circulating RBC population
38-43
. 
Removal of RBCs from nutrients in circulation begins a “starvation time,” which 
in some studies is used interchangeably with “storage time.” During starvation, 
plasticizers from blood bags may leach into the stored blood, and thus back into 
the body upon reinfusion, and is one opportunity for detection
44
. Several studies 
show significant changes in cell morphology, termed “lesions”, the severity and 
irreversibility of which increase with increasing storage time
38
. Changes of this 
nature are responsible for a heterogeneous size distribution in the stored RBC 
population – more advanced storage lesions lead to vesiculation of the cell, thus 
decreasing its size. Decreased size of the RBCs is shown to increase the overall 









. Alterations to the cell size also inherently alters its 
electrophoretic behavior; Harrison et al. have shown promising results using 




 Electrophoretis, and dielectrophoresis (DEP) in particular, is often used as 
a metric for diagnostics and separation. These spectroscopy techniques are 
frequently implemented for a multitude of diagnostic and quantitative assays. 





, and enhanced sensitivity of microfluidic biosensors
47
, 




, among many other 
targets
51-53
. DEP theory of particles and cells is well explored; mobility and 
behavior is shown to be sensitive to changes in particle and cell size and 
structure
54-57
, and is thus a potential assay to probe changes in RBC physiology 
induced by storage lesions, which include changes in cell interior and membrane 
composition.  
 When stored ex vivo, RBCs begin to lose a number of membrane-bound 
proteins
58
. This physiological change offers less surface proteins, which we aim to 
exploit to reveal age-based differences in dielectrophoretic spectra for stored cells 
compared to that of fresh RBCs. These changes to the cell structure and 
composition invariably lead to changes in the electrical properties and thus the 







discrepancies in protein content of bovine red blood cells (bRBCs) by cross-
linking the cells and performing dielectrophoretic (DEP) spectroscopy, which has 
shown significant changes in DEP behavior with increased bRBC starvation
59,60
. 
We use these same differences in these spectra to discern storage-related changes 
to human RBC morphology and composition, as a means to directly detect 
autologous blood doping in athletes. 
 Using a combination of membrane protein cross-linking and DEP 
spectroscopy, we demonstrate the ability to directly detect the presence of 5%, or 
one transfusion unit, of RBCs in fresh blood. 
 
4.2 Materials and Methods 
 
4.2.1 Device Fabrication 
 In this section we describe the methods used to prepare the blood samples 
and fabricate the device with which the dielectrophoretic analysis is performed. 
The complete electrode fabrication method has been described in detail in a 
previous publication
47
. Briefly, thin layers of chromium and gold are deposited 
onto coverglass by electron beam deposition and patterned using 
photolithography and wet etching techniques. The resulting electrodes are a 
quadrupole electrode array (Figure 4.1), which has well-defined regions of high 







distinct regions allow a greater separation of sample subpopulations. Wire 
connections are soldered and connected to a function generator (Agilent 
Technologies, Inc.) to supply the electric field. Indium tin oxide (ITO) electrodes 
are created using a lift-off method, in which the photoresist is applied before 
depositing the metal and subsequently washing with acetone to remove the 
photoresist and excess metal.  
 All experiments were performed by pipetting a small prepared droplet (~2 
uL) onto the bare quadrupole. This method is adequate for characterizing the DEP 
spectra, but becomes less robust for the application of detecting blood reinfusions. 
A large majority of the droplet remains outside of the influence of the electric 
field, and these cells must gravity settle before they begin to feel any electrical 
stress. The developed testing chamber forces cells into an area within the field, 
where the number of cells within the testing chamber can be controlled by 
modifying the concentration of the prepared sample. This enables DEP 
quantification of the same cells across the entire spectrum. We make the 
quadrupole array out of ITO, which in thin films becomes transparent, allowing 
visual discrimination of the cell positions. 
 The DEP testing chamber and valve system are created using classical soft 
lithography techniques used to create microfluidic devices
2
, and will not be 
discussed in depth here. Multilayer devices, such as valve systems, require 
additional steps
61







220, DOW) that produces rounded channels capable of being completely sealed 
off by an upper layer. The upper valve layer is cast in a negative photoresist (SU-
8 3050, Microchem Corp.) at a 30 m thickness. The flow channels are spin-
coated with polydimethylsiloxane (PDMS) in a 20:1 ratio of elastomer-to-curing-
agent to a thickness of 20 m; the upper layer is poured in a 10:1 ratio. The two 
layers are cured at 85 °C for 15 minutes, aligned under an inverted microscope, 
plasma bonded, and baked for an additional 2 hours. The resulting device is 
plasma bonded to the electrodes and baked overnight before use. 
 
4.2.2 Blood Sample Preparation 
 All solutions and buffers were prepared with 18.2 MΩ water. All studies 
are performed with approval from the Homewood Institutional Review Board 
(HIRB) after procedure overviews and informed consent forms are signed by 
volunteers of their own volition. After an alcohol swab, a finger stick (Owen 
Mumford) sample of blood is allowed to pool on the fingertip and is 
quantitatively collected by pipette. The sample is added to a microcentrifuge tube, 
and citrate phosphate dextrose (CPD) is added in a 1:8 ratio of anticoagulant-to-
whole blood before storing at 4 °C in a blood bank refrigerator. For purchased 
blood samples: 10 mL whole blood in CPD (Zen-Bio, Inc.) are divided into 
aliquots upon arrival and stored at 4 °C in a blood bank refrigerator (Jewett). For 







10X PBS stock (Quality Biological). The sample is centrifuged at 2000 relative 
centrifugal force (rcf) to pellet the RBCs, and the supernatant is pipetted off and 
replaced with fresh 1X PBS. The washing procedure is repeated twice more.  
 After the third wash, the supernatant is again replaced with fresh 1X PBS. 
The appropriate volume of stock glutaraldehyde (25% w/v)(Polysciences, Inc.) is 
added to the fresh RBC suspension to give the desired fixative concentration, 
ranging from 0.15-5.0% w/v glutaraldehyde (glt). Fixation begins immediately 
upon addition of glutaraldehyde, and the samples are allowed to fix by gentle 
mixing on a shaker (ThermoFisher) for 1 hour at 22°C. Post-fixation washing 
steps are performed three times with 1X PBS at 6500 rcf for 5 minutes to remove 
residual glutaraldehyde. A final washing step is performed with a solution of 0.8-
3M 6-aminohexanoic acid (AHA), a low conductivity zwitterion. AHA has been 
shown to reduce the range of the DEP spectrum to frequencies achievable by less 
sophisticated waveform generators, in addition to showing increased stability of 
unfixed cells compared to other low conductivity buffers
62
.  
 RBC cell suspensions received from collaborators at San Diego State 
University (SDSU) arrived pre-fixed with 2.5% w/v glt according to the 
aforementioned protocol, and are suspended in 1X PBS. These samples are 
washed three times at 6500 rcf for 5 minutes before a final washing step with and 







 To stain the RBCs for fluorescent imaging, Vybrant, a lipophilic dye 
(ThermoFisher), is added to the washed cell suspension and allowed to incubate 
according to the vendor protocol. The cells are then washed again before 
performing the simulated reinfusion and fixation. Staining the RBCs before or 
after the fixation step results in significant loss of RBCs in subsequent washing 
steps. To begin staining, 5 µL of stock dye was added per 10
6
 cells. The 
appropriate quantity of 25% glt was then added to yield the final weight percent 
of glt. These samples were allowed to fix for 1 hour at 22 °C. Post-fixation 
washing steps in this case are performed at 2000 rcf for 5 minutes.  
 
4.2.3 Dielectrophoretic Analysis 
 Cells and shelled particles are shown to exhibit multiple DEP regimes
63-66
. 
Plotting the defined Claussius-Mossotti (CM) factor: 
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  is defined as the effective complex permittivity for a cell containing 
cytoplasm and membrane regimes  
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for a model cell whose characteristic electrical properties are assumed to be: [ m = 








, yields three distinct regions of relative polarizability that are sensitive to 
disturbances in the electrical properties that govern each regime. Because our 
suspending buffer, AHA, has a low relative conductivity and a high permittivity, 
an electrical mismatch is produced at the edge of the cell membrane, driving 
charge accumulation at this interface. At relatively low frequencies (< 200 kHz), 
the electrical stress produced drives the cell to regions of lowest field strength, 
termed negative DEP (nDEP). Because the mechanism producing this conductive 
polarization requires physical migration of free ions, it is inherently frequency 
dependent. When the frequency increases such that the ions cannot electromigrate 
quickly enough to accumulate, they relax at what is known as their characteristic 
relaxation time scale, defined as  = [( 2+ 1)/( 2+ 1)] at each interface. In cells, 
this relaxation often results in a change of sign in relative polarization, producing 
a physical crossover frequency (cof) at which the cells cross over from regions of 
low field strength (nDEP) to regions of high field strength, or positive DEP 
(pDEP) (Figures 4.1(a) & 4.2(a)). As the field penetrates into the cytoplasm, the 
conductive charging mechanism begins anew; because we choose a buffer with a 
high permittivity, the relaxation timescale of the cell interior produces a second 








Figure 4.1. Micrographs of red blood cell DEP on a quadrupole electrode array. (a) RBCs at low 
frequencies are drawn to regions of high field strength (pDEP). (b) At high frequencies, RBCs 
cross over to regions of low field strength (nDEP). Scale bars 50 µm. 
 
 
Figure 4.2. Isolated DEP microfluidic testing chamber. (a) RBCs showing pDEP inside the testing 
chamber at low AC field frequency. (b) RBCs showing nDEP inside the testing chamber at high 
AC field frequency. (c) Multi-layer microfluidic testing chamber with valves intersecting main 
flow channel on either side of the testing chamber. Integration of transparent ITO electrodes 








 Characterization of the DEP spectrum and analysis of the mixed blood 
samples are performed with the previously mentioned quadrupole electrode array. 
Approximately 2 µL of the fixed blood suspension are pipetted onto the electrode 
array, and an AC field is driven through the droplet by a function generator 
(Agilent Technologies). The frequency is slowly increased from 50 kHz to 10 
MHz, and the beginning and end of the two crossover frequencies is recorded. 
The crossover frequency is sensitive to changes in the electrical properties, which 
are in turn sensitive to changes in age and storage time. These changes are tracked 
and used to determine the presence of stored RBCs in a fresh blood cell 
population. 
 In the valve system, a droplet of prepared blood is pipetted onto the inlet 
port and drawn into the testing chamber by applying vacuum to the outlet. The 
valve channels are dead-end filled with water and subsequently pressurized to 20-
30 psi to instantaneously halt the flow of the sample and isolate the testing 
chamber. Once the DEP characterization is complete, the valves are released and 
the testing chamber is flushed with water and loaded with a new sample (Figure 
4.2(c)). 
 








4.3.1 Characterization of the DEP Spectrum 
 To determine the optimal degree of fixation required to maximize 
resolution, and thus separation between storage times, we sample stored aliquots 
of purchased whole blood as they age over a period of 4-6 weeks. During this 
time, the cells undergo a starvation process that alters the protein content of the 
membrane and interior, providing fewer sites for fixation. The fixation is 
performed over a range of 0.15-2.5% w/v glt, and the second cof, or high cof, is 
measured. In this work, we investigate only the high cof, as this is where we have 
seen the greatest measureable change with time, and the low cof is often lowered 
to frequencies that result in Faradaic reactions on the electrode surfaces (< 40 
kHz). The beginning of the cof is marked when the first cells cross over into the 
field minimum in the center. The frequency is increased until all cells have been 
removed from the high field regions – this is the end frequency of the cof. The cof 
is reported as the average of these two values and plotted as functions of storage 
time as well as weight percentage of glt.  
 
Figure 4.3. Effects of fixation and storage time on RBC crossover. (a) Increasing % glt increases 







to deplete RBC proteins, leaving fewer proteins available for fixation and decreasing the hCOF. 
(b) All percentages of glt collapse to a single dominating trend of decreased hCOF with storage 
time. 
 
 We observe that the cof decreases with increasing storage time for all 
weight percentages of glt. Increasing degree of fixation within the cell slightly 
increases the cof but does not appear to increase or significantly optimize the 
resolution between week 1 and week 4 of storage (Figure 4.3). Unless otherwise 
specified, all subsequent experiments are performed at 2.5% w/v glt. 
 
4.3.2 Volunteer Samples 
 For volunteers, all personal data identifiers are rendered anonymous for 
publications., we collected fingerprick samples from graduate student volunteers 
once a week for 6 weeks. After the last sample collection, simulated reinfusion 
samples are created, and all aliquots are prepared for testing and undergo DEP 
spectroscopy (Figure 4.4). In this case, we see decreased resolution between 
storage times, compared to the DEP spectroscopy results from purchased vials of 
blood (Figure 4.3(b)). We hypothesize that discrepancies in the aliquot sizes may 
be a significant factor. Cell starvation in this decreased fingerstick sample volume 
is likely quite different from a 1 mL aliquot as well as a full blood bag, and thus 








Figure 4.4. DEP of grad volunteer samples. The same trend is observed as for vendor-supplied 
blood. We note that the overall decrease in hCOF is dimished here compared to vendor samples, 
which we attribute to large discrepancies in aliquot size between these sources. 
 
 To create a robust assay for use in athletic settings, we try to eliminate or 
reduce the possibility of false positives, and deduce whether exercise itself alters 
the DEP spectrum. From SDSU collaborators, we received blood samples from 
cyclists before and after a 5-hour bike ride, and label the samples pre (A) and post 







Figures 4.5 & 4.6. In Figures 4.5(a) & 4.6(a), the breakdowns are shown by 
average overall cof. In Figures 4.5(b) & 4.6(b), the lower and upper bars represent 
the lowest frequency at which the cells begin to crossover, and the highest 
frequency at which the cells finish crossing over, respectively. The lower and 
upper boundaries of the box represent the average frequency at which cells begin 
to cross over, and the average frequency at which the cells finish crossing over, 
respectively. The midline of the box is the overall averaged cof. In all 
representations of the data, we conclude that the spectra remain significantly 
unchanged, and that exercise does not seem to shift the spectra, although further 
sampling is required to increase the reliability of the assay to 99.9%. 
 
Figure 4.5. Effects of exercise on athlete COF. (a) The average COF is plotted for the whole group 
before (AGrouped) a 5-hour cycling session, and after (BGrouped). (b) A more complex breakdown of 











Figure 4.6. Individual effects of exercise on athlete COF. (a) Individual COFavg is plotted before 
and after the 5-hour cycling session, displayed side-by-side for each athlete, where the control is a 
non-athlete. (b) Complex breakdown of individual COFs plotted side-by-side for each athlete 
before and after the 5-hour cycling session. 
 
4.3.3 In Vitro Autologous Reinfusion 
 We perform a simulated reinfusion of 1 unit of stored blood, which will 
account for approximately 5% of the total blood volume. To separate the 
subpopulations, we apply a frequency between 0.7-1.0 MHz, where fresh cells 
still experience pDEP (Figure 4.7(a)) but the same cells at 4 weeks of storage time 
have already crossed over (Figure 4.7(b)). In the reinfusion, the presence of cells 
in the field minimum is indicative of reinfused cells whose cof has dropped with 
storage time and have crossed over earlier than the fresh population. We verify 
this by performing the same reinfusion with stained cells. Fresh cells are stained 







4.7(c)). While this experiment is not fully representative of the complex 
physiological processes undergone during an autologous transfusion, the ability to 
electrically detect differences in cell age and composition is a crucial step in the 
development of a robust detection assay. 
 
Figure 4.7. Visualization of a simulated reinfusion and fluorescent confirmation of detection. (a) A 
fresh (Day 1) blood sample under AC field at 800 kHz. Fresh cells exhibit pDEP exclusively. (b) 
Simulated reinfusion of 5% Day 28 blood in 95% Day 1 blood under AC field at 800 kHz. The 
presence of cells in the center (low field region) presenting nDEP is suggestive of “doping.” (c) 
Fluorescent microscopy confirms detection. Fresh cells are stained red and show pDEP, while 4-
week cells are stained green and exhibit nDEP. Scale bars 50 µm. 
 
4.3.4 In vivo Autologous Transfusion 
 In this study, a group of 3 cyclists underwent true autologous blood 
transfusions of one pint of blood. Athletes are given anonymous data identifiers 
AT1-3. Blood samples for testing were taken immediately prior to reinfusion 
(DPRE), immediately after reinfusion (D0), and intermittent days 1-6 days after 
reinfusion (D1, 2, …, 6). We observe an immediate drop in COFavg post transfusion 







post transfusion. It is interesting to note that individual cells from the reinfused 
subpopulation were not trapped at frequencies below the baseline COF, as was 
observed in the in vitro transfusions. Instead, the process of an autologous 
transfusion appears to affect the entire circulating blood population, lowering the 
COFavg compared to its pre-transfusion baseline (Figure 4.8). Figure 4.9 provides 
a more complex breakdown of the decreasing COF for each athlete. We further 
illustrate this lowering of the COFavg by comparing micrographs of the athletes 
AT1 (Figure 4.10) and AT3 (Figure 4.11) over the time before and after reinfusion, 
where all images are held at the same applied frequency. The presence of cells in 
the low field region, in additional to pearl-chaining RBC between the electrode 
gaps, is evidence of a lowered COF, and is shown as a steady decrease 








Figure 4.8. Effects of autologous blood transfusion on COF. Three athletes having undergone a 
one-unit autologous transfusion display a significant decrease in the COF of the whole blood 
population. Doped COF values here were selected from the days after transfusion that displayed 








Figure 4.9. Complex breakdown of the effects of autologous blood transfusion on COF. Athlete 
COFs decrease slightly after reinfusion, and continue to decrease in the week following. A 
baseline sample was not provided for subject AT1. 
 
 
Figure 4.10. Illustration of decreased COF in subject AT1. (a) Immediately after transfusion (D0) 
at 0.4 MHz. (b) 6 days after reinfusion (D6) at 0.4 MHz. The presence of cells crossed over and 









Figure 4.11. Illustration of decreased COF in subject AT3. (a) Prior to reinfusion (Dbase) at 0.4 
MHz. (b) Immediately after reinfusion (D0) at 0.4 MHz. (c) 1 day post reinfusion (D1) at 0.4 MHz. 
(d) 3 days post reinfusion (D3) at 0.4 MHz. Scale bars 50 µm. 
 
4.4 Conclusions 
 We have shown the ability to detect changes in the DEP spectra of fresh 
and aging blood populations, and the ability to separate these mixed populations 
in an in vitro simulated reinfusion of 1 unit of blood. Cell starvation produced 
storage lesions that resulted in changes to the cell composition, which we were 
able to detect with DEP spectroscopy. We were able to use these differences to 
probe a mixed blood population and visibly separate the reinfused subpopulation 
from the fresh sample. We have also shown the ability to detect the presence of a 
true in vivo autologous transfusion, though this assay must be tested further to 
increase its detection capabilities to the requisite 99.9% accuracy. This can be 
obtained, along with complete objectivity and confidence of measurements, by 
application of an automated DEP platform (3DEP, Labtech International Ltd.) 
67,68
. With an automated system, this DEP assay can used either as an invaluable 
















Real-time deformability cytometry (RTDC) for 




 The intensely competitive nature of endurance sports drives athletes to 
great lengths in order to secure victory. When conditioning isn’t enough, athletes 
turn to artificial means of enhancing their aerobic performance, utilizing a variety 
of blood transfusions in an attempt to edge out their competitors. These methods 
are banned not only by domestic entities like the U.S. Anti-Doping Agency 
(USADA) 
69
, but by a number of international organizations, including the World 
Anti-Doping Agency (WADA) 
27
 and the International Olympic Committee 
(IOC) 
70
. Advancing our ability to detect these methods is crucial, as they remain 







 Autologous blood transfusions (ABT), the donation and storage of one’s 
own blood for later reinfusion, is currently the most sophisticated method of 
blood doping. This method is typically practiced by hospitals and the military for 
patients undergoing surgery and in the event of traumatic blood loss
71-75
, however, 
athletes have adopted ABTs in an effort to enhance their oxygen carrying capacity 
and remain undetected by doping agencies. 
 Refrigerated blood bags under proper storage conditions are shown to be 
viable for reinfusion up to 35 days, as approved by the FDA
76
. For blood frozen in 
glycerol, the viability extends past 10 years
77,78
. Given that 4-6 weeks are required 
to recover hemoglobin mass after a 1-unit donation
79
, autologous blood must be 
stored at least this long for an athlete to expect full therapeutic effects. There is 
evidence that blood cells stored for these periods of time undergo irreversible 
changes to their physiology and morphology
38
. Some of these changes may be 
reversible upon reinfusion, but increasing storage times are linked to an increasing 
population of irreversibly changed cells, greatly increasing the risk of local 
hypoxia, stroke, and multiple organ failure
80,81
. While there seem to be little to no 
changes in RBC morphology and physiology by cryopreservation in glycerol, 
excluding possible hemolysis during freeze and thaw processes, there is a 
correlation of dangerous side effects associated with transfusions of this nature – 










 With the risks presented, athletes continue to practice blood transfusions 
as a means enhance aerobic performance. The Athlete Biological Passport (ABP) 
35,36
, first adopted by the Union Cycliste Internationale (UCI) and subsequently by 
most other sports organizations, including WADA, is the current paradigm for 
anti-doping drug testing. This long-term tracking of hematological biomarkers is 
meant to preserve a record of an athlete’s blood profile, and use deviations as 
indicators for potential doping. This multifaceted approach is evolving and largely 
effective but relies on a compilation of indirect markers and subjective 
interpretation of data and would benefit from the addition of a direct detection 
assay. 
 Microfluidics presents a real-time solution to many bioanalytical assays, 





and single cells studies
85-87
. The continuous flow nature of microfluidic devices 
makes them ideal for biodetection applications, where fouling of solid, stationary 
substrates found in traditional biosensors is often an issue. Microfluidics has also 
been used as a platform for shear-induced RBC deformation studies
88-90
. But age-
related studies using this platform remains largely uninvestigated.  
 Otto et al recently used microfluidics as a means of mechanically probing 
the viscoelasticity of polymer spheres and cells
89
. Utilizing a microfluidic 
constriction, the cells are subjected to shear forces that deform the cells to a 







With the use of a high-speed camera and proprietary software, the cells can be 
imaged inside of the constriction and their deformation extracted in real time. We 
have applied the same mechanical principle to the deformation of red blood cells, 
in an attempt to determine differences in storage time by probing their 
deformability. The deformability of RBCs is known to decrease in external 
storage conditions, as shown by Berezina et al in micropore filtration 
experiments
38
. We anticipate that stored cells will present with less elasticity and 
a lower degree of deformation that can be analyzed by direct measurements of the 
cells as they actively squeeze through a microfluidic constriction, as opposed to 
their fresh, circulating counterparts. 
 
5.2 Materials and Methods 
 
5.2.1 Device Fabrication 
 Microfluidic devices are created using standard photolithography and soft 
lithography techniques, which are detailed elsewhere. Briefly, negative 
photoresist (SU-8, MicroChem Corp) is spun onto a 4-inch wafer (University 
Wafer) after dehydration baking and is exposed to a UV source (KLOÉ) to 
produce a master mold. The elastomer polydimethylsiloxane (PDMS) is mixed in 
a 10:1 elastomer-to-curing-agent ratio and poured over the wafer. After curing at 







biopsy punch (Ted Pella, Inc.), the PDMS is plasma bonded to coverglass (no 1, 
ThermoFisher) to create microchannels. Fluid is delivered to the device via 
syringe pump (KD Scientific) at a constant flow rate of 0.75 L/min, unless 
otherwise specified. 
 
5.2.2 Blood Sample Preparation 
 All solutions are made with 18 MΩ deionized water. With Institutional 
Review Board (IRB) approval and informed consent, finger prick blood samples 
were collected from volunteers with fingertip lancets (Owen Mumford) and stored 
in citrate phosphate dextrose (CPD)(Sigma Aldrich) in a ratio of 1:8 
anticoagulant-to-whole-blood. All blood samples and aliquots are stored at 4 °C 
in a blood bank refrigerator (Jewett). Where otherwise specified, blood is sourced 
from a single vendor (Zen-Bio) and aliquoted in volumes of 0.5–1.0 mL before 
storing in the blood bank refrigerator. For non-human mammalian (herein refered 
to as “animal”) samples, bovine (cow), ovine (sheep), caprine (goat), and equine 
(horse) blood was purchased from Quad Five with citrate anticoagulant and 
aliquoted in volumes of 0.5-1.0 mL on arrival and stored in a blood bank 
refrigerator. 
 To prepare for RTDC, a small volume of blood is removed from an aliquot 
and diluted in 1X PBS. The diluted blood is washed in a centrifuge (Microfuge 







the pellet is resuspended in fresh 1X PBS. After the third removal, the pellet is 
resuspended in 1X PBS with 0.5% wt methylcellulose (mc) (M0512, Sigma 
Aldrich), unless otherwise specified. The final resuspension must achieve a ratio 
of 1:50 whole-blood-to-buffer, determined by the initial whole blood volume 
removed from the aliquot. 
 
5.2.3 Real-Time Deformability Cytometry 
 RTDC utilizes a combination of microfluidic sheath flow and 
hydrodynamic shear stress to flow focus a stream of RBCs into a narrowed 
channel (Figure 5.1). The strong velocity gradient within the constriction 
produces high shear rates at cell edges nearest the walls, deforming the cells 
without making contact with the channel walls. This greatly reduces clogging, 








Figure 5.1. Brightfield view of RTDC microfluidic device. Cells are centered by the sheathing side 
streams and funneled into the constriction where they are imaged by a high-speed camera. Scale 
bar 200 µm. 
 
 Flow behavior in the area of interest, the microfluidic constriction, is 
simplified to be described using the classical fluid transport problem of flow 
around a sphere, the analytical solution for which is derived using stream 
functions and presented as
91
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with Legendre polynomials      and constants         determined from no 







From Equation 1 we observe that hydrodynamic shear forces are maximized at 
     , or at the cells edges closest to the channel walls. 
 The above theory does not fully describe the demonstrated phenomena. 
Highly deformable cells being advected into the microfluidic channel present a 
complex analytical problem beyond a simple stream function. Mietke et al have 
developed a full analytical model for the flow field around a viscoelastic sphere 
advected in a microfluidic channel
91
.  
 The constriction is designed and fabricated such that the average size of 
the cell is 50-90% of the channel size, providing high shear rates and 
deformations that are visually observable and quantifiable. Microfluidic sheathing 
into the constriction centers RBCs as they advect through the channel at speeds on 
the order of 5-10 cm/s, which beyond the imaging capability of most standard 
microscope mounted cameras. The use of a high-speed camera (Fastec Imaging) 




 cells in a single video encompassing approximately 7 
seconds at a capture rate of 5100 frames/sec (fps). 
    
    
 
       (2) 
 The projected area (A) and cell perimeter (P) are measured and used to 
calculate the circularity           . Deformation (D) is then quantified as 








5.3 Results and Discussions 
 
5.3.1 Buffer Optimization and Device Calibration 
 The imaging challenges associated with accelerating cells through a 
constriction on the order of 10 cm/s necessitate the use of a high-speed camera, 
for now. To optimize the detection assay, we hold the flow rate constant and 
instead vary the viscosity of the suspending buffer, increasing the stress without 
impeding the ability to effectively image the cell speeding through the 
constriction. We vary the 1X PBS buffer from 0-1.0% mc, 0.2 um filtering the 
buffer before use. The degree of deformation is dependent on the hydrodynamic 
shear forces of the constriction acting on the cell, which can be modulated by 
changing the medium viscosity; optimizing this force is crucial to the resolution 
of the measurements. Insufficient shear will not act on the fresh cells enough to 
fully express their inherent deformability; excessive stress will over-shear both 
fresh and aged cells to the extent that they become indistinguishable. 
 From Figure 5.2, we see that for methylcellulose content lower than 0.75% 
mc, there are apparent differences in deformation, which may be differentiable 
but are not maximized. For content greater than 0.85% mc, the apparent 
differences begin to diminish, due to the increased deformation of the aged cells 
as a direct result of the increased viscosity and thus shear force. The shear forces 







corresponds to a viscosity range of approximately 5-15 centipoise (cP). We run all 
subsequent experiments at 0.5% mc, corresponding to a buffer viscosity of 15 cP. 
 
Figure 5.2. Optimization of the viscous cell medium. Increasing the viscosity of the buffer 
enhances differences between fresh and aged blood to an extent – increasingly viscous buffer (> 
0.75% mc) begins to lose resolution between the populations. 
 
 Vesiculation under storage conditions reduces the overall size of the cell
43
; 
because this process is irreversible, size is a popular metric to ascertain the state 
of aged and reinfused cells
45
. In the interest of developing a robust assay for 
detecting subtle changes specifically in RBCs, we opt to calibrate our sensor with 
RBCs of several different non-human mammals. The distribution of cell size and 







regardless of the inherent size distribution within each mammal. The average 
sizes for each mammal are given as such in Table 5.1:  





Cow 4.5 ± 1.93 0.357 ± 0.053 
Goat 4.11 ± 1.87 0.290 ± 0.045 
Sheep 3.90 ± 1.87 0.067 ± 0.027 
Horse 4.75 ± 2.13 0.195 ± 0.039 
 
 With 400+ cells analyzed, the clustering of the species cells is observable 
in Figure 5.3. An ANOVA analysis confirms this separation (P < 0.0001, R
2
 = 
0.8686). Given that the average size deviations of these mammals from humans 
ranges from 1 – 5 µm, their separation is a good indicator of RTDC as a sensitive 
means to mechanically probe visually indiscernible differences in cell size and 








Figure 5.3. Deformability analysis of non-human mammalian RBCs. For four different species, 
four groupings can be seen and statistically verified. 
 
 
5.3.2 RBC Deformability with Increasing Storage Time 
 To determine the presence of aged cells, the deformability spectrum must 
be characterized over the duration of the storage period. The deformability 
spectrum shown in Figure 5.4 is observed to decrease with age, rapidly over the 
first 4 weeks, and more slowly over the remaining 2 weeks. While the initial 
decrease is observable and distinguishable, the likelihood of recovering reinfused 







changed cells is quite low. With increasing storage time, however, this population 
increases; by extension, late-stage reinfusions, with their irreversibly diminished 
size and cytoskeletal content, should be the easiest to detect. 
 
Figure 5.4. Deformability analysis of human RBC over storage time of 42 days (vendor-sourced). 
RBCs show an average decrease in deformability of 0.21, 50.61%. As storage time increases, the 
percentage of irreversibly changed and vesiculated cells increases, leading to further reductions in 
deformability. 
 
 Plotting only the fresh and most aged blood samples, we see an average 
decrease of cell size of 1.75 um
2







50.61% (Figure 5.5(a)). We can create the same plot with blood samples donated 
from graduate student volunteers, following IRB protocol. After 6 weeks of 
storage, we observe an average decrease in cell size of 7.46 um
2
, 25.09%, and 
decreased deformability of 0.20, 50.65% (Figure 5.6(a)). Plotting the cell 
perimeter vs. the projected cell area in Figures 5.5(b) & 5.6(b) illustrates another 
means of visualizing the effects of decreased deformability, where the dotted line 
represents P=A. As the cells age in storage, storage lesions both decrease the 
deformability and overall size of the cells. As a result of these changes, the cell 
perimeter in the constriction is greatly reduced and the projected area is 
decreased, respectively. These changes lead the cell to a decreased ratio of P/A, 
placing them closer to the P=A line. We observe that many cells cross this line 
into the region where P/A<1, though a large portion of the cells remain above this 








Figure 5.5. Overall change in deformability of vendor-sourced human RBCs. (a) Cells show a 
decreased size of 1.75 um
2
, 7.91%, and decreased deformability of 0.21, 50.61%. (b) In a 
perimeter vs area plot, all fresh cells present well above the P = A line, indicating a ratio P/A > 1. 
The majority of aged cells present below this line, with an overall ratio P/A < 1. 
 
 
Figure 5.6. Overall change in deformability of grad volunteer human RBCs. (a) Cells show a 
decreased size of 7.46 um
2
, 25.09%, and decreased deformability of 0.20, 50.65%. (b) In a 
perimeter vs area plot, the majority of fresh cells present above the P = A line, indicating a ratio 
P/A > 1. The majority of aged cells present below this line, with an overall ratio P/A < 1. 
Differences in the degree of change and P/A ratios between blood from two different sources 
(vendor-sourced vs. grad volunteers) may largely be due to biological variance, though variations 









 Differences in the degree of change between the two samples sources 
(Figures 5.5 & 5.6) may largely be due to biological variance, though variations in 
aliquot storage volume are suspected to be a factor. We speculate that blood aging 
in small volumes (>0.2mL) differs greatly from aging in larger (0.3–1mL) or even 
relevant (>100mL) whole blood volumes, making studies using full blood bags 
imperative. Nonetheless, given the presented differences between the fresh and 
aged cells, real transfusion detection becomes feasible. It is likely that RBC 
vesiculation is accelerated in smaller volumes, accounting for the larger decrease 
in average cell size, though the viscoelasticity of the cells appears equally 
diminished in both cases. 
 
5.3.3 In Vitro Autologous Transfusion 
 After characterizing the deformability behavior of the aging cells, we 
perform a simulated reinfusion of 2 units of blood; this corresponds to 
approximately 10% of the total blood volume. For this experiment, we again use 
graduate student donors. After mixing a 6-week sample into a freshly collected 
sample, the new “reinfused” sample is prepared and run through the RTDC 
device. With only 300 cells analyzed, we see a subpopulation emerge outside the 
spread of the main cluster; this grouping is believed to be a direct result of the 







shows a decreased deformability of 54% and good recovery of the reinfused cells, 
approximately 70% recovery of the total 10% reinfusion. We expect the recovery 
of these cells can be improved with increasing sample size.  
 
Figure 5.7. Deformability analysis of grad volunteer in vitro transfusion. A mixture of 90% fresh 
blood and 10% day-42 blood is analyzed and presented. (a) The clustering of a subpopulation 
outside the main grouping may be indicative of “doping.” This outlying group represents 
approximately 7% of the reinfused portion, indicating 70% recovery of the reinfused cells. (b) 
Perimeter versus cell area. The presence of a removed, isolated group below the P = A line may be 




 We have presented the ability to use RTDC as a means to mechanically 
probe differences in RBC populations, both in animals and humans. We also 
present the ability to determine the presence of an in vitro autologous transfusion 
from fingerprick samples of blood with good recovery of reinfused cells. While 







for analysis of many different types of cells, provided the constriction size is 
changed to suit individual experimental needs. With minimal sample preparation 
required, this method becomes ideal for routine and spot testing; the absence of 
molecular tags and specialty reagents makes the tests themselves of negligible 
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Microfluidic bubbler facilitates near complete mass 
transfer for sustainable multiphase and microbial 
processing  
 
 A microfluidic device (channels <70µm) was utilized to create micro-scale 
bubbles to significantly increase mass transfer efficiency at low flow rates. The 
convergence of one gas and two liquid channels at a Y-junction generates bubbles 
via cyclic changes in pressure. At low flow rates, the bubbles had an average 
diameter of 110 µm, corresponding to a volumetric mass transfer KLa of 1.43 h
-1
. 
Values of KLa normalized per flow rate showed that the microbubbler had a 100-
fold increased transfer efficiency compared to four other commonly used 
bubblers. The calculated percentage of oxygen transferred was approximately 
90%, which was consistent with a separate off-gas analysis. The improved mass 
transfer was also tested in an algae bioreactor in which the microbubbler absorbed 







alternative needle bubbling method. The microbubbler yielded a cell density 82% 
of the cell density for the alternative needle tip with an 800-fold lower flow rate 
(0.5 mL/min versus 400 mL/min) and a 700-fold higher ratio of biomass to fed 
carbon dioxide. The application of microfluidics may transform interfacial 
processing in order to increase mass transfer efficiencies, minimize gas feeding, 
and provide for more sustainable multiphase processes. 
 
6.1 Introduction 
 Mass transfer from a gas to a liquid plays a critical role in many 
multiphase processes spanning multiple industries. Some example applications of 
gas to liquid transfer occur in biological processing in which carbon dioxide is 
transferred to liquid media for algae cell growth and oxygen is transferred to 
bacteria fermentation broths and mammalian cell culture bioreactors. Other 
applications include gas sequestration, chemical manufacturing 
(hydroformylation, alkylation, carboxylation, and polymerization) and 
hydrometallurgy
92
. In most cases, especially in industrial settings, companies and 
researchers desire an optimal transfer of the mass to the liquid in order to 
minimize the amount of gas fed to the multiphase process. 
 Obtaining a high mass transfer rate is ideal for processes that occur 
rapidly, such as microbial fermentation, because the dissolved solute has to be 







applications involving expensive gases, the goal is to achieve the highest fraction 
of the gas transferred to the liquid. For example, algal cells absorb carbon dioxide, 
which can then be converted to lipids for the production of biofuels. In addition, 
microbes can serve to capture carbon dioxide from the atmosphere as one 
potential approach to lower the carbon dioxide concentration in the atmosphere 
and reduce the accumulation of this greenhouse gas. Similarly, oxygen sparging is 
critical to aerobic respiration for bacteria producing biochemicals and mammalian 
cell lines generating biopharmaceuticals. However, much of the carbon dioxide to 
algal cultures or oxygen fed to mammalian and bacterial bioreactors is not 
successfully dissolved into the liquid broth and as a result, the undissolved gas 
passes directly through the bioreactor
93
. In these cases, the energetic output and 
costs associated with the gas sparging are wasted and must be repeated until 
sufficient solute is dissolved in the target liquid media. Alternatively, it would be 
highly desirable to deliver a higher fraction of the feed gas into the liquid solution 
as part of these multiphase processes. 
 The process of mass transfer from gas to a liquid occurs in three steps 
according to Whitman's two-film theory of gas absorption
94-96
. The first step 
involves the transfer of the component from the bulk of the gas, through the gas 
boundary layer, and to the phase boundary between the gas and liquid. 
Differences in partial pressures provide the driving force for this first step. The 







between the liquid and gas; this step is assumed to be extremely rapid and in 
equilibrium relative to the other steps. The third step transfers the component 
from the phase boundary through the liquid boundary layer to the bulk liquid. 
This step depends on the difference in concentration in the liquid of the 
component for the driving force
96
. From the bulk liquid, the dissolved component 
can then undergo other steps through chemical reactions or transport into cells. 
The overall transfer rate (Na) from the bulk gas to bulk liquid depends on the 
volumetric mass transfer coefficient (KLa) and the concentration difference for 
poorly soluble gases (e.g., oxygen and carbon dioxide in water) as the driving 
force, according to Equation 6.1. 
          
         (6.1) 
 Therefore, the overall transfer rate depends on three factors: the overall 
mass transfer coefficient (KL [distance/time]), the driving force in terms of 
concentration difference between the solubility limit in the liquid (Ca
*
) and the 
dissolved solute concentration (Ca
*
), and the ratio of surface area to volume for 
the gas–liquid interface (a [distance
−1
]). While the driving force (Ca
*
 −  Ca) can be 
increased by decreasing the temperature, increasing the overall pressure of the 
system, or by feeding pure gas instead of diluted gas, these approaches may not be 
feasible and can add to the overall costs. 
 Another option to increase mass transfer is to increase KL by increased the 







Alternatively, the interfacial area contribution may have the largest impact on 
mass transfer and represents a significant opportunity to improve the overall 
transfer rate. One approach is to take advantage of the surface area to volume 
ratio, a, which depends inversely on the characteristic bubble length. In this way, 
improved control and reduction in the size or distribution of the size of bubbles 
can increase mass transfer effectiveness. 
 By decreasing the bubble size, one can also lower the bubble velocity and 
conversely increase the bubble rise time. In this way, the overall time spent on 
interfacial gas exchange can be enhanced by decreasing bubbler diameter. Given 
the importance of bubble size to mass transfer for biological and other processes, 
methods dedicated to greater control of bubble size will become increasingly 
important in order to enhance chemical and biochemical interfacial process 
sustainability. Microfluidics is a useful tool for generating and controlling 
micron-scale gas bubbles and manipulating bubble interfacial area, rise time, and 
consequently the mass transfer rate and efficiency. 
 Previous researchers have used microfluidic devices to generate bubbles 
and drops for a variety of different applications. For example, T-shaped channel 
junctions have been used to create micro-emulsifications of monodispersed 
bubbles, anisotropic particles in the microchannels, and to generate and control 
microbubbles in oil
97
. A variety of different channel geometries have been 









. These tests have been performed for a variety of Reynolds numbers 
in different settings, primarily for bubble creation into liquids with high 
viscosities in microscopic settings
97
. 
 To increase the mass transfer in a macroscopic setting, we utilized a 
microfluidic device to create micro-scale bubbles, increasing the surface area to 
volume ratio and, therefore, the KLa. Flow focusing microfluidic devices have 
previously shown the ability to produce stable micron sized bubbles with T-
shaped junctions by having two liquid streams and one gas stream combine at the 
junction
97
. Instead of using a T-shaped junction, we utilized an angled, Y-shaped 
junction because we found the Y-junctions produced more uniformly shaped 








Figure 6.1 Design and size specifications of the Y-junction of the microfluidic device used to 
make micro-scale bubbles. The inlet channels for the liquid and the gas channels are 25 mm and 
the gas channel tapers to 10 µm at the junction which forms at a 40° angle. The outlet channel is 
66.67 µm. Bubbles form in the junction, cutting off flow from the liquid channels except for a 
thin, wetting strip along the walls of the channel. The liquid pressure builds up and cuts off the 
bubble at the orifice. This process causes a cyclic bubble generation. 
 
 In the microfluidic device, both liquid and gas are driven into the channels 
using an externally applied pressure gradient at near identical pressures. The 
liquid enters through the top inlet port and splits into two symmetric side channels 
(Supplementary Figure S6.1). These two liquid channels combine, at a 40° angle, 
with a central gas channel (Supplementary Figure S6.1). Bubbles are generated 
using hydrodynamic flow focusing; the gas stream is focused into an orifice using 







pinched to create a steady stream of monodisperse gas bubbles. We 
experimentally optimized the dimensions of our device so each individual bubble 
displaces the two liquid streams at the junction, temporarily cutting off fluid flow 
except for a thin wetting stream along the walls of the outlet channel. The wetting 
stream prevents the bubble from sticking to the sides of the channel and 
disrupting flow. As the bubble size and surface area increase, the influence of 
viscous drag from the two liquid streams eventually becomes larger than the 
interfacial forces holding the bubble at the nozzle, and the bubble detaches. When 
a continuous flow of liquid and gas are supplied, this process is repeated 
producing nearly identical bubbles at a constant frequency. 
 The channel width affects the size of the produced bubbles and the rate of 
delivery of gas to the system. Under the conditions used in this work, the bubble 
diameter is approximately equal to the width of the channel. Because bubbles are 
generated using an external hydrodynamic shear stress, which serves to pinch off 
the bubble during formation, we can increase the bubble diameter by increasing 
the channel width. However, increasing the channel width also decreases the flow 
rate of delivery of the gas to the system as an equivalent pressure will provide 
lower flow rates to a device with a larger cross-sectional area perpendicular to the 
flow direction. Conversely, one could produce, in theory, nanoscale drops with a 
nanoscale fluidic geometry. However, this would require much more complicated 







micron-scale particulate impurities in the streams. The devices utilized in this 
work were near the minimum channel size for feasibility and was based on a 
balance of these two factors. 
 In this study, we found that we could significantly increase the KLa and 
the efficiency of gas transfer to a liquid culture through the application of such a 
microfluidic device. This device enabled the generation of micro-scale bubbles at 
low flow rates, significantly improving the KLa per flow and the fraction of the 
gas transferred to the liquid. Ultimately, the applicability of the device was 
validated by supplying carbon dioxide to a fermentation system growing the green 




6.2.1 Microfluidic Fabrication 
 For the fabrication of the microfluidic flow-focusing devices, we used 
well-developed soft lithography techniques. Negative photoresist (SU-8 3050, 
Microchem Corp., Westborough, MA) was spin-coated onto a silicon wafer 
(Silicon Inc., Boise, ID) and exposed to a UV light source (KLOÉ) through a 
negative mask printed on a transparency. The result, after developing, was a 
silicon wafer with raised structures 60 μm high that act as the master mold with 







form to the outlet port being 2 mm. A 10:1 ratio of the elastomer and curing agent, 
PDMS, is poured over the wafer, cured, and peeled off. Biopsy punches (Ted 
Pella, Inc., Redding, CA) are used to create inlet ports for the fluid flow. The 
surface of both the PDMS and a cleaned microscope slide are treated with oxygen 
plasma and placed in contact to form a bond; the bonded devices are baked at 
85°C overnight to enhance this bond. Fluid and gas streams are delivered via 
pressurized vials to deliver a constant flow rate. The outlet stream, consisting of 
media and microbubbles, exited the outlet port through tubing with an inner 
diameter of 0.02 inches and into the bottom of the liquid vessel. 
 
6.2.2 KLa determination 
 Values for KLa are difficult to calculate and usually are determined 
experimentally. To determine the KLa values for different systems, we placed 
500 mL of water at 25°C in a beaker with a diameter of 10 cm, giving a liquid 
height of 6.36 cm. We placed a dissolved oxygen (DO) probe (Vernier) in the 
liquid and stirred the liquid with a magnetic stirrer at a constant agitation rate of 
175 rpm. The computer captured and recorded DO readings every second. 
Initially, we fed air to the bottom of the liquid until the DO was constant at the 
saturation point. Then, we fed nitrogen gas into the culture to drop the DO. Once 
the DO dropped significantly, we switched the gas feed back to air and monitored 









 − Ca) for the segment of interest after the switch back to air
99
. In this case, 
Ca
*
 is the highest concentration of the DO, achieved at the beginning of the trial, 
and Ca is the DO for the rest of the trial. For the segment of interest, the resulting 
graph of the ln(Ca
*
 − Ca) over time produces a straight line with a negative slope 
(Supplementary Figure S6.3). The KLa is the slope multiplied by negative one and 
has units of inverse time. 
 
6.2.3 Fraction of Oxygen Transferred 
 The fraction of oxygen transferred calculation were verified utilizing an 
oxygen gas sensor (Vernier) with the KLa testing. The oxygen gas sensor was 
sealed to the top of the off-gas above the liquid the KLa testing was done on and 
recorded the oxygen gas concentration every second. As nitrogen gas was fed to 
the liquid, the DO and the oxygen gas concentration decreased. When we bubbled 
air into the system to test the KLa, the oxygen gas sensor recorded the change in 
oxygen concentration, which allowed for the calculation of oxygen gas 
concentration in the bubbles. The trend line used to determine the oxygen gas 
concentration in Figure 6.7 was calculated using the LINEST linear regression 
least square method on Microsoft Excel. This method also provides an estimate of 
the coefficient of determination (R
2
) and errors for both the slope and intercept for 







 Closed containers were used and the dissolved oxygen and oxygen gas 
concentrations were measured. After switching from the nitrogen feed to air fed 
through the microfluidic bubbler, the dissolved oxygen concentration increased 
while the oxygen gas levels in the headspace declined due to the oxygen transfer 
from the bubbles to the liquid. As a result, the bubbles leaving the liquid had been 
stripped of much of the oxygen and thus contained primarily nitrogen and the 
other components of air, without oxygen. The oxygen deprived bubbles emerging 
into the head space caused the oxygen gas concentration in the head space to 
decline gradually as these oxygen-deprived bubbles replaced the off-gas 
headspace previously containing a mixture of air and nitrogen. 
 
6.2.4 Additional Bubbling Equipment 
 Four common additional methods of supplying gas to liquids for mass 
transfer were tested against the microfluidic bubbler and included an open-tube, 
needle tips, a common aquatic stone sparger, and an industrial sparger used for 
bioreactors. The open-tube was a Bellco Glass straight sample metal pipe with an 
inner diameter of 0.5 cm and an outer diameter of 0.625 cm. The needles used to 
supply gas were stainless steel, 19 gauge, 4″ long, blunt end luer needles. The 
common aquatic sparger was the small air stone cylinder from Active Aqua with a 
diameter of 1.7″ and a height of 2.0″. The industrial sparger was a Bioengineering 








6.2.5 Gases and Liquids 
 The liquid used to perform all of the experiments was a salt media 
commonly used for algae culture, Bold's Basal Media (BBM) 
100
. BBM media 
contains 250 mg/L sodium nitrate, 175 mg/L potassium phosphate monobasic, 
75 mg/L magnesium sulfate heptahydrate and potassium phosphate dibasic, 
50 mg/L EGTA, 31 mg/L potassium hydroxide, 25 mg/L calcium chloride 
dihyrdate and sodium chloride, 11.42 mg/L boric acid, 8.82 mg/L zinc sulfate 
heptahydrate, 4.98 mg/L iron sulfate heptahydrate, 1.57 mg/L copper sulfate 
pentahydrate, 1.44 mg/L manganese chloride tetrahydrate, 0.71 mg/L 
molybdenum trioxide, 0.49 mg/L cobalt nitrate hexahydrate, and 1 μL sulfuric 
acid with the pH adjusted to 6.8. This media was also supplemented with 0.5% 
pluronic F-68 as a surfactant to stabilize bubble formation. The addition of 
pluronic F-68 has shown no negative effects on algal cell growth and has been 





 The bubbles in the microfluidic channels were analyzed with a Nikon TI-E 
confocal microscope. The probes measuring dissolved oxygen, oxygen gas, and 
carbon dioxide gas were from Vernier and were recorded every second during 







liquid, a Sony Cybershot DSC-H20 camera was used and ImageJ was used to 
analyze bubble size. 
 
6.2.7 Algae Cultures 
 The strain C. vulgaris (UTEX 395) was grown in 500 mL of BBM media 
in a bioreactor with a total volume of 1.25 L. Gas was fed as 5% CO2 in air at a 
flow rate of 400 mL/min for the needle tip culture and 0.5 mL/min for the 
microbubbler. The bioreactors operated at room temperature (∼23°C) with an 
agitation rate of 200 rpm and a constant light intensity of 10,000 lux 
(∼300 μE/m2/s). Growth was recorded by measured optical density at 600 nm 
using a Promega Glomax multidetection spectrophotometer. Carbon dioxide 




6.3.1 Bubble Size 
 The purpose of using the microfluidic bubbler is to create micro-scale 
bubbles to increase the mass transfer from gases to the bulk liquid. As a 
representative case study, we bubbled air through the liquid algae growth 







in Figure 6.1. For bubble flow, the pressure of the liquid and gas streams were set 
at similar pressures and then adjusted to facilitate bubble formation in the 
channels. Next, the size and distribution of bubble sizes produced in the liquid 
were evaluated. Shown in Figure 6.2(a) is an image of the bubbles produced in the 
liquid while Figure 6.2(b) shows the bubbles produced from a typical industrial 
sparger. Shown in Figure 6.3 is the size distribution of the bubbles produced using 
the microbubbler following multiple trials. The distribution shows that the 
bubbles from the microfluidic device averaged 110 microns in diameter. This 
normal distribution provides more precise bubble production, compared to the 








Figure 6.2 Bubble images. (a) Bubbles in liquid created by microfluidic bubbler at a flow rate of 
0.50 mL/min and (b) bubbles in liquid created by the next smallest alternative, the industrial 
sparger at 500 mL/min. 
 
 
Figure 6.3 Bubble diameter distribution. The average bubble size from the microbubbler with a flow rate of 
0.50 mL/min was 110 mm with a standard deviation of 30 mm with a maximum size of 180 mm and 
minimum size of 50 mm.  
 
 In order to see how the bubble size of the microfluidic bubbler compared 
to a range of other devices for supplying gas, we compared the microfluidic 
device to an open-tube, a needle tip, an aquatic sparger, as well as an industrial 
sparger gas feeding system. Shown in Figure 6.4 is the average bubble size 
determined for the other four methods as a function of gas flow rate. Firstly, the 
microfluidic bubbler operates at a much lower flow rate than the other methods, 







500 mL/min for the open-tube, needle, aquatic sparger, and industrial sparger, 
respectively. At lower flow rates, the other devices did not produce bubbles into 
the liquid media. At extremely low flow rates, below ∼1 mL/min, the bubbles of 
the microfluidic bubbler were all well below 1000 μm in diameter with the lowest 
average diameter of 110 μm. The microfluidic device, needle, and open tube 
exhibit the requirement of trailing gas being pinched off to form bubbles, showing 
an increase in bubble size with flow rate. The bubble size stayed relatively 
constant for both spargers based on the pore size of the spargers, leading to the 
industrial sparger having slightly smaller bubble diameters due to smaller and 
more concise pores. The spargers created no bubbles below 500 and 750 mL/min 
for the industrial sparger and the aquatic sparger, respectively, due to too low of a 
pressure to push the gas through the pores. 
 
Figure 6.4 Bubble size dependence on flow rate for all devices. All bubble sizes increase with 







smallest bubbles, followed by the industrial sparger, aquatic sparger, then the needle, and finally 
the open-tube. 
 
6.3.2 Volumetric Mass Transfer Coefficient (KLa) 
 The goal of the microbubbler is to make gas solutes available in solution 
more efficiently than conventional spargers. Therefore, the KLa was analyzed for 
the microbubbler, as shown in Figure 6.5(a) for the lower flow rates achieved. 
Interestingly, the KLa value for the microfluidic bubbler increased with increasing 
flow rate until 2.6 mL/min, corresponding to a KLa of 5.22 h
−1
. After this peak, the 
KLa decreases gradually with increasing flow rate up to 8.2 mL/min, 
corresponding to a KLa of 4.16 h
−1
. 
 Because the flow rates of the systems were orders of magnitude apart and 
increasing flow rate increases KLa for most devices, the KLa values were 
normalized by taking a ratio of the KLa multiplied by the volume of liquid 
(constant) and divided by the flow rate, making this value dimensionless
103,104
. 
Previous modeling studies have normalized the KLa with the flow rate and 
volume
105
. Shown in Figure 6.5(b) are the normalized KLa values for the 
microfluidic bubbler compared to the open-tube, needle, and sparger systems. 
According to the normalized KLa values, the microbubbler system is 
approximately 100 times more efficient in transferring mass from a gas to a liquid 








Figure 6.5 KLa of the microbubbler compared to other methods. (a) KLa dependence on flow rate 
for the microfluidic bubbler. (b) All of the KLa values for all systems were normalized with flow 
rate and volume of liquid. The microbubbler had a 100-fold better transfer per flow rate than the 
other four methods. 
 
6.3.3 Fraction Oxygen Transferred 
 In order to test how much of a particular solute is transferred from the 
microbubbles into solution, we calculated the fraction of oxygen transferred to the 
liquid (δ), by utilizing the KLa, Ca
*
, height (h) and cross sectional area (Ac) of the 
liquid perpendicular to the flow, flow rate of the gas (  ) and the density of the 




       
       
    
    (6.2) 
 Shown in Figure 6.6 are the values of fraction of oxygen transferred for 
different sparging devices. The fraction of oxygen transferred for the industrial 
sparger increases from 0.003 to 0.011 for flow rates of 500–1100 mL/min and the 







1,000 mL/min. Conversely, the fraction transferred for the open-tube decreases 
from a maximum of 0.01 to 0.004 for flow rates from 100 to 1000 mL/min while 
the needle tip stays approximately constant at a fraction transferred of 0.002 for 
flow rates of 500 to 800 mL/min. In contrast, the microfluidic bubbler provides a 
significantly higher fraction of oxygen transferred of 0.91 (±0.15) and 0.90 
(±0.13) at the lowest flow rates of 0.5 and 1.2 mL/min, respectively, indicating 
near complete transfer of oxygen. 
 Unlike the other devices, the fraction of oxygen transferred increases with 
decreasing flow rate for both the microfluidic bubbler and the open-tube device 
(Figure 6.6). Both the spargers increased the fraction of oxygen transferred with 
higher flow rates because the bubbles remained relatively constant in size 








Figure 6.6 Fraction of oxygen transferred dependence on flow rate. Fraction oxygen transferred 
dependence on flow rate for all systems. For low flow rates (0.5 and 1.2 mL/min) of the 
microfluidic bubbler, the fraction oxygen transferred is approximately 0.90 whereas the fraction 
transferred for the other systems is generally <0.01. 
 
 As a secondary approach for evaluating the fraction of oxygen transferred, 
the oxygen gas levels in the headspace were measured using an oxygen gas sensor 
throughout the KLa trials. The oxygen gas concentrations (CO), the volume of the 
head space (V), and the flow rate (Q), can be used to calculate the concentration 
of oxygen in the bubbles leaving the liquid (G) using a modified dilution 
ventilation equation (Equation 6.3) 
107
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     (6.3) 
 Integration of this equation can be used to calculate the average 
concentration of oxygen in the outlet bubbles (Equation 6.4). The fraction of 







the concentration of oxygen in the outlet bubbles by the concentration of oxygen 
in room air (209 parts per thousand [ppt]). 
  
       
 
          
 
 
   
 
          
 
 
    (6.4) 
 Shown in Figure 6.7 is the concentration of oxygen in the sealed 
headspace for KLa testing of the microbubbler with a flow rate of 0.50 mL/min. 
The beginning of the oxygen transfer to the liquid (∼17.5 min) began at the time 
at which nitrogen gas feeding was stopped and the microfluidic bubbler began 
flowing air into the media (see Materials and Method for KLa determination). 
When the bubble of air enters the liquid, it consists of air (78% nitrogen, 21% 
oxygen, 0.9% argon, 0.04% carbon dioxide, and minor other components with 
less than 0.01%). As the bubble travels through the liquid, the oxygen will diffuse 
into liquid based on the solubility of the gases in the liquid. Therefore, when the 
bubble leaves the liquid and enters the headspace, it will have a different 
composition than entering the liquid. The oxygen level in the headspace 
progressively declined as a result of the transfer of oxygen from the bubbles into 
the liquid, leading to the replacement of oxygen with nitrogen in the headspace. 
The average concentration of oxygen in the bubbles leaving the liquid can be 
calculated by measuring that change of oxygen concentration in the headspace. A 
line of best fit for the headspace oxygen concentration was applied from the 







concentration of oxygen in the bubble exiting the liquid, G, according to Equation 
6.4. Calculations indicated that the bubbles exiting the liquid contained 
approximately 38.06 ppt oxygen, which corresponds to about 18% of oxygen in 
room air and a fraction of oxygen transferred of 0.82 ± 0.08. Thus, the off gas 
fraction of oxygen transferred is similar in value to that calculated using Equation 
6.2 (0.91 ± 0.15), at an equivalent flow rate. 
 
Figure 6.7 Oxygen concentration in headspace above KLa testing with an air flow rate of 0.50 
mL/min for fraction oxygen transferred calculation. The equation of the line of best fit for the 
change in oxygen concentration (ppt) with time (min) is given by y = –0.0745x + 144.39 with a 
coefficient of determination of R
2
 = 0.9. The drop over time corresponds to a transfer of 82 ± 8% 
of the oxygen in the air to the liquid. 
 
 Once, we established that the microfluidic bubbler provided optimal 
conditions for transferring solutes from gas to a liquid, the frequency of bubble 







see if it can be adjusted for larger reactor sizes (Supplementary Figure S6.5). 
Below 30 cm in liquid height, the frequency of bubble generation stayed 
approximately constant at 2–18 bubbles/s for flow rates of 0.22–0.98 mL/min, 
respectively. With increasing flow rates, we expect higher bubble frequencies and 
larger heights at which the microbubbler can operate. 
 
6.3.4 Microbubbler in an Algae Culture 
 We next examined the transfer of carbon dioxide, another sparingly 
soluble gas, to a growing microalgal culture. The KLa value of carbon dioxide can 
be estimated by relating the measured KLa of oxygen in the system and applying 
the diffusivities of both gases, as described below in Equation 6.5
108
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   (5) 
A culture of C. vulgaris was grown using both the microbubbler and the needle 
tip with flow rates of 0.5 and 400 mL/min, respectively (Table 6.1). The cells 
were grown for 240 h and then growth and processing parameters were estimated 
and compared. 
 As shown in Table 6.1, the culture with the needle tip at a flow rate two 
orders of magnitude higher exhibited a slightly higher growth rate and a final 
OD600 of 0.841 compared to 0.703 for the microbubbler. This OD corresponds to 







microbubbler. In addition to the final cell densities, the carbon dioxide 
concentrations in the headspace of the reactors were compared. Table 6.1 also 
shows the carbon dioxide concentration in the headspace for the microbubbler 
was less than 10% of the concentration of that in the headspace of the needle tip. 
Furthermore, given that the feed gas contained 5,000 parts per million (ppm) 
CO2, the microbubbler culture transferred more than 90% of the CO2 in the feed. 
In contrast to this finding, the headspace for the needle feed had 98% of the feed 
gas concentration, meaning only 2% of the CO2 in the feed gas was transferred to 
the culture. Overall, the total CO2 fed/g of biomass generated was 2.9 g/g for the 









Table 6.1 Performance of the microbubbler in an algae bioreactor.  
 
 
6.3.5 Estimate of Gas Feed Costs for Large Scale Algal Bioreactors 
 Another relevant consideration of the microfluidic bubblers is whether 
these devices are cost efficient for transferring solute at larger scales. As a first 
approximation, the cost of inputs was compared for the devices based on the 
amount of mass transferred (Table 6.2). Device capital and pumping costs were 
ignored for this initial comparison but can be added in more detailed comparisons. 
In this analysis, the cost of media and gas needed/L to run a typical microalgae 
bioreactor with BBM media using 10% CO2 in air at a required absorption rate of 
162 mL of CO2/min/L culture were considered. An estimated required value of 
162 mL CO2/min/L culture is calculated from the maximum theoretical 
photosynthetic rates of algal cultures using an estimated average cell density of 
1 × 108 cells/mL and ignoring shading effects
109
. 
 We estimated the amount of gas input given the fraction of the gas 
transferred for each input system, since all systems except the microbubbler will 
require much higher flow rates to transfer a sufficient amount of gas for cellular 







nearly four times lower for the microbubbler when compared to the next most 
efficient systems, the open-tube and industrial sparger. Other systems, such as the 
needle sparger and aquatic sparger, exhibit processing costs that were orders of 
magnitude higher due to the high amounts of CO2 that must be pumped through 
these spargers to provide for sufficient dissolved CO2 in the algal bioreactors. 
This fourfold decrease to the cost of pumping gas decreases the cost of feeding 









 In this study, we demonstrated that Y-junction microfluidic devices are 
able to form stable, small bubbles for use in transferring mass from gas bubbles to 
liquid. The small standard deviation on the bubble size distribution and the fact 
that 85% of the bubbles fall within a 75 micron span (75–150 μm) show that the 
microfluidic bubbler creates near constant bubble sizes at constant, low flow 







increasingly important in processes in which it is important to reliably control all 
parameters, such as in complex biological processes or chemical reactions. This 
ability to fine tune the sizes of the microbubbles will be especially critical for 
modeling and control purposes. 
 At low flow rates, the microfluidic bubbler generates bubbles much 
smaller than the other systems, showing it outperforms the other system in 
creating small bubbles, especially at low flow rates. For the microfluidic bubbler, 
the open-tube, and the needle tip, the bubble diameter becomes larger with 
increasing flow rate, seen in Figure 6.4, consistent with findings from papers 
analyzing macroscopic bubble creation
112,113
. The spargers' bubble sizes are 
maintained with flow rate, because the gas is pushed through the constant sized 
pores equally, creating relatively constant bubble sizes. 
 Another benefit to the microfluidic bubbler system is the low flow rates 
for operation. In contrast, the open tube, needle tip, aquatic sparger, and industrial 
sparger had minimum flow rates of 100, 400, 700, and 500 mL/min, respectively. 
Below those flow rates, the systems formed no bubbles. The low flow rate of the 
microfluidic bubbler allows for a smaller amount of feed gas to form bubbles, 
which can generate significant savings for processes that use expensive gases. 
Because many processes, especially in an industrial setting, need a large flow rate 
of the gas, we can combine multiple devices in parallel to increase the total flow 







adjusting the flow rate because raising the flow rate increases bubble diameter and 
lowers the efficiency of the transfer. 
 To verify that smaller bubbles improve mass transfer due to the larger 
surface area to volume ratio, we measured the KLa over a range of flow rates for 
the microfluidic bubbler. The KLa value for the microfluidic bubbler peaks at a 
flow rate of 2.6 mL/min. The peak occurs because as the flow rate starts to 
increase further, the bubble size increases. The larger bubble diameter gives the 
bubbles a larger volume, increasing the buoyant force on the bubbles, causing the 
faster rise velocity of the bubbles
108
. This increased buoyant force causes the 
bubbles to rise out of the liquid faster, giving less time for transfer. Below the 
peak rate, the KLa decreases because there is a smaller amount of total gas mass 
released into the liquid. Less oxygen is introduced to the system due to the low 
flow rates and bubble generation frequency, causing the dissolved oxygen 
concentration to not increase as rapidly, lowering the overall KLa
105,114,115
. 
 Comparing the microfluidic bubbler to the other devices in terms of the 
KLa normalized with flow rate demonstrates the benefits of the bubbler compared 
to other systems that have much higher flow rates. The aim of the microfluidic 
bubbler is to increase the mass transfer from gas to liquid while minimizing the 
amount of feed material necessary and improving efficiencies of delivery. Even 
though the KLa values for all of the systems, including the microbubbler, are 







magnitude smaller than the other systems. Therefore, the KLa normalized per flow 
rate of the microfluidic bubbler is 100 times more efficient at transferring 
mass/amount of material fed. Lowering the flow rates of the other systems to 
create smaller bubbles and improve KLa values to those comparable to the 
microfluidic bubbler would be difficult to implement. For these systems, the KLa 
values increase significantly with higher flow rate, so decreasing the flow rate 
will likely lead to lower KLa values (Supplementary Figure S6). Using the 
microfluidic bubbler system, the most time efficient (highest KLa) system used a 
flow rate of 2.6 mL/min, while the most complete transfer (highest KLa per flow 
rate) occurred at low flow rates of 0.5 mL/min. 
 The fraction of oxygen transferred decreased with increasing flow rate, 
similar to bubble size (Equation 6.2). The increased bubble size gave faster rise 
velocities and less time for the oxygen to transfer from the bubble to the liquid. At 
the lowest flow rates for the microfluidic device, the fraction of oxygen 
transferred was approximately 90%, indicating almost complete transfer of the 
oxygen from the air to the liquid. We verified this calculation by analyzing the 
off-gas as part of the KLa measurements (Figure 6.7). By measuring the change in 
the sealed headspace oxygen, the amount of oxygen transferred was estimated at 
82 ± 8%, which is similar to the value of 91 ± 15% determined by Equation 6.2. 







bubbler improves gas mass transfer while minimizing the amount of feed gas 
necessary. 
 Although these results are significant advancements at the laboratory 
scale, it will be important to demonstrate scalability for larger vessels and in 
commercial application. We have shown that this bubbler system at low flow 
rates works extremely well in volumes of liquid with heights up to 32 cm 
(Supplementary Figure S6.5). It can also work effectively at heights above this by 
increasing the pressure that drives the liquid and gas feeds. Increasing the flow 
rates also produces a higher frequency of bubble generation, as verified by 
others
116,117
. One aspect of the microbubblers that could pose a challenge for 
industrial use is that the pressure drop required for generating gas and liquid feed 
scales linearly with the device dimensions. In other words, a larger bubbler would 
require an equally larger pressure drop to produce the necessary bubble rate for 
industrial bioreactor use. These pressures could place new constraints on both the 
microfluidic device materials required to safely work under these pressures and 
the costs associated with continuously sustaining them in the bioreactor. Although 
our devices can sustain 40 psi before the microfluidic channels rupture and 
debond from the glass substrate, future work will be needed to evaluate the 
feasibility of building devices at higher operating pressures as needed. 
Alternatively, smaller devices can be deployed in parallel and these permit 







 The flexibility of using different liquid operating heights provides a wide 
range of operating conditions and applications. For example, a microbubbler can 
be applied for bubbling gas to algal ponds in long raceways with shallow depths. 
This device can also be used in mammalian and bacterial cultures for optimal feed 
of oxygen for maximizing growth. 
 When implemented into an algal bioreactor, the microbubbler showed a 
much better fraction transferred and better overall growth and consumption of 
carbon dioxide than other bubbling methods in terms of total flow rate (Table 
6.1). Obtaining nearly equivalent biomass with a flow rate 800 times lower 
demonstrates the substantial potential enhancements in mass transfer obtained 
using the microbubbler. Approximately 80–90% of the CO2 was transferred in the 
microbubbler compared to only 2% for the needle tip approach, a 45-fold 
improvement in CO2 transfer and utilization. The needle tip fed 1,900 g of CO2/g 
of biomass whereas the microbubbler only fed 2.9 g of CO2/g of biomass, an 
almost 700-fold improvement. 
 Such an approach of using low flow rates with smaller bubbles for 
increased mass transfer can help provide significant cost savings by improving the 
efficiency of the transfer and limiting the amount of feed gas used (Table 6.2). 
The economic analysis for Table 6.2 takes into account the cost of gas to feed to a 
typical algae bioreactor, the volume of the reactor, the flow rate of the gas, and 







require a lower flow rate of gas, potentially leading to a decrease in operating 
cost. From this analysis, the microfluidic bubbler is four times more cost efficient 
because of the lower requirement for feed gases. Furthermore, the savings of the 
microfluidic bubbler increase with larger systems and with extended use to 
suggest that this device will have value in a commercial setting. However, final 
costs must also consider start-up costs of a microfabrication facility and costs 
associated with pumping the gases through the microbubbler devices. The 
implementation of a clean room and equipment used for microfabrication include 
negative photoresists, developer solution, transparency mask, spin coater, mask 
aligner with ultraviolet (UV) lamp, and a tesla coil or oxygen plasma. The largest 
of these costs come from the costs for a clean room and a mask aligner with UV 
lamp. However, smaller, mobile clean rooms can be significantly less expensive, 
which can dramatically decrease the up-front manufacturing costs. However, once 
the equipment and clean room are in place, the cost of manufacturing the 
microfluidic bubblers is extremely low because the materials for making the 
devices (polydimethylsiloxane [PDMS] and cover slips) are inexpensive. 
 The benefits of increased mass transfer due to low flow rates and small 
bubbles help make this microfluidic bubbler a more efficient method of bubbling 
gases through a liquid. Carbon dioxide, oxygen, and other important gases, such 
as helium, can be sequestered from the gas phase by dissolving them into liquids 







microbubbler also may be used for flocculation of microorganism cultures for 
more efficient harvesting
118
. This approach will allow users to harness and control 
gas delivery to liquids more effectively for a wide spectrum of engineering 
applications that could transform interfacial processing in the coming decades 








6.5 Supplementary Materials and Figures 
 
Supplementary Figure S6.1 Microfluidic bubbler channel and mask design. Liquid enters through 
the PDMS to the top port where it splits into two channels. The two liquid channels converge with 
the gas channel that enters at a different location. These channels combine to form bubbles that 









Supplementary Figure S6.2 Dissolved oxygen concentration over time for the calculation of KLa. 
Air is sparged into the system to obtain the baseline dissolved oxygen concentration, then nitrogen 
gas is sparged into the liquid to remove the dissolved oxygen. After the dissolved oxygen drops, 
air is fed back into the liquid and the increase in dissolved oxygen is recorded. 
 
 
Supplementary Figure S6.3 Plot of the natural log of the saturation dissolved oxygen 







section when air is sparged back into the system after nitrogen gas. The KLa is calculated as the 
negative slope of the line. 
 
Supplementary Figure S6.4 Histogram of bubble distributions for other sparging methods. Figures 
show the distribution of bubble sizes along with average, standard deviation, minimum, and 









Supplementary Figure S6.5 Bubble frequency dependence on height of liquid for a range of flow 
rates. Bubble frequency stayed constant up to ~32 cm and increased with increased flow rates. 
 
 
Reprinted with permission from Biotechnology and Bioengineering
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, copyright 










Label-free biomolecular detection at electrically 
displaced liquid interfaces using interfacial 
electrokinetic transduction (IET)  
 
 
 Biosensors require a biorecognition element that specifically binds to a 
target analyte, and a signal transducer, which converts this targeted binding event 
into a measurable signal. While current bio- sensing methods are capable of 
sensitively detecting a variety of target analytes in a laboratory setting, there are 
inherent difficulties in developing low-cost portable biosensors for point-of-care 
diagnostics using traditional optical, mass, or electroanalytical-based signal 
transducers. It is therefore important to develop new biosensing transducer 
elements for recognizing binding events at low cost and in portable environments. 
Here, we demonstrate a novel electrokinetic liquid biosensing method for the 
sensitive label-free detection of a model biomolecule against a background of 







electrical liquid interface when subjected to an external alternating current 
electrical field. We demonstrate that the electric field-induced motion of the 
interface can be used as a sensitive and specific transducer for the detection of 
avidin at femtomolar concentrations in solution. This new detection strategy does 
not require surface functionalization or fluorescent labels, and has the potential to 
serve as a sensitive low-cost method for portable biomarker detection. 
 
7.1 Introduction 
 Biosensors combine targeted biological recognition with physicochemical 
transduction to detect specific biomolecules within a biological sample. They are 
used in a wide range of analytical applications, including diagnosis and treatment 











 and point-of-care 
diagnostic testing
130,131
. Here, we address a key challenge to developing label-free 
homogenous biosensors for sensitive bio- molecular detection and kinetic analysis 
using microfluidic bio- sensing systems that normally require fluorescently 
labeled bio- molecules and optical quantification. 
 Combining biosensors with microfluidic transducers can fulfill an 
increasing demand for fast, inexpensive sensors capable of molecular detection 
and analysis. Microfluidic biosensors provide several advantages over traditional 







sample and reagent consumption, and potential automation with sample 




  and 
detectors. In micro- fluidics, liquid transport usually occurs at low Reynolds 
number where the fluid flow is laminar; fluid streams flow side-by-side and 
mixing is driven only by diffusion
134-136
. 
 Microfluidic liquid interfaces have been used as homogenous biosensing 
substrates for quantitative molecular detection and kinetic analysis in solution 
phase. The interface is created using laminar flow, where two streams combine at 
a fluidic junction and flow side-by-side down a main channel. One stream has a 
target probe and the second stream contains the biological sample of interest
137,138
. 
Biorecognition occurs in solution phase as the target and sample streams 
diffusively mix at their contacting liquid interface where target and sample 
molecules specifically bind to one another. This approach offers an inexpensive, 
yet extremely powerful method for biosensing and biomolecular kinetic analysis, 
and has been used to quantify fast kinetic processes, extract kinetic rate constants, 
perform sensitive on-chip immunoassays and detect DNA hybridization reactions 
in solution. 
 To create a complete biosensor, the microfluidic interface is coupled with 
a transducing element to convert recognition events into a detectable 
measurement signal. Depending on the nature of the transduced biosensor signal, 













Biosensing at microfluidic liquid interfaces, however, is currently only performed 
using optical methods such as fluorescent microscopy, fluorescence energy 
transfer (FRET) 
143
, fluorescence correlation spectroscopy
144
, confocal fluorescent 
microscopy
145
, and fluorescence lifetime imaging microscopy (FLIM) 
146
. While 
effective, they require fluorescently labeled probe molecules and optical 
components, which can significantly increase the cost and size of the microfluidic 
platform. 
 
Figure 7.1 Biosensing T-channel schematic. (a) Microfluidic T-channel device with integrated 
electrodes used to create an electrical liquid interface for the IET sensor. Scale bar 5.0 mm; (b) 
schematic illustration of target-probe binding along the liquid interface; and (c) principles of IET 
sensor operation – (1) specific binding occurs at the electrical interface; (2) an electric field 
polarizes and displaces the interface a distance Δd, which is a function of the field frequency; (3) 
binding influences the polarizability of the interface and is detected by measuring interface 
frequency response at different values of field frequency. 
 
 We report a label-free homogeneous electrokinetic biosensor for detecting 
and quantifying bioaffinity interactions in solution. Our approach combines 
continuous microfluidic flow with alternating current (AC) electrokinetics. 














 and fluidic routing
150
. In our electrokinetic approach, 
depicted in Figure 7.1, bioaffinity binding occurs at a microfluidic liquid 
interface. We create the interface using a microfluidic T-channel device with two 
fluid inlets and a single fluidic outlet; two fluids combine at the channel junction 
and create an interface as they flow side-by-side down the main channel to the 
outlet (Figure 7.1(a)). An array of microelectrodes is fabricated in the main flow 
channel and used to deliver a polarizing electric field across the fluid interface. To 
be polarizable, and capable of being manipulated with the applied electric field, 
we engineer an electrical mismatch into the interface. In this way, the interface is 
an electrical interface (EI), comprised of two co-flowing fluid streams with 
different electrical conductivity (σ) and permittivity (ε). Using the EI as a 
substrate for biomolecular reaction, two solutions – one containing a target 
protein and the other containing an analyte probe – are pumped into separate T-
channel inlets at a constant flow rate, inter-diffuse across the EI and specifically 
bind at the liquid interface (Figure 7.1(b)). During this process, an AC electrical 
field is applied across the EI. Due to the large electrical mismatch, the interface 
polarizes and electro- kinetically displaces across the main flow channel, 
perpendicular to the main flow direction (Figure 7.1(c)) 
151
. The magnitude and 
direction of this displacement is proportional to the electrical mismatch at the EI. 







mismatch, and allow for biomolecular interactions to be detected and quantified 
without fluorescent labels by measuring the interfacial displacement under an 
external electric field during binding (Figure 7.1(c)). 
 Our label-free biosensing method uses the liquid interface as a 
homogenous substrate for specific binding, and its motion in an AC electric field 
as the transducer for biomolecular recognition. We therefore propose a new class 
of biosensors based on interfacial electrokinetic transduction (IET): specific 
binding changes the electrical properties at the EI, which is electrokinetically 
transduced and detected by measuring perturbations in field-induced fluid 
displacement. 
 In this work, we demonstrate how to use IET to monitor avidin–biotin 
binding kinetics in real-time without labels. Moreover, the IET biosensor is 
specific and sensitive, and able to detect as low as 250 femtomolar avidin 
concentrations against a 5mg/mL background of bovine serum albumin (BSA). 
Through this study, we establish a methodology for rapid label-free IET 
biosensing at electrical liquid interfaces, demonstrate sensor performance and 
sensitivity for the detection of biomolecules, and measure avidin– biotin binding 
kinetics with millisecond time resolution. This new electrokinetic sensor can 
provide a low-cost, rapid, and portable biosensing system for label-free real-time 








7.2 Materials and methods 
 
7.2.1 Microfluidic device fabrication 
 Experiments were performed using the microfluidic T-channel device 
shown in Figure 7.1(a). It was fabricated using standard soft photolithography and 
microfabrication techniques. First, micro- channel electrodes were fabricated 
using wet chemical etching. Glass cover slips (50   30 mm2, No. 1, Fisher 
Scientific) were coated with 20 nm of chromium and 50 nm of gold using electron 
beam evaporation. The cover slips were patterned with photo- resist (Shipley 
1813) and exposed metal was etched using gold and chromium etchant creating an 
array of patterned metal electrodes. The microchannel was fabricated in PDMS 
(Momentive, RTV 615A). A 10:1 mixture of PDMS elastomer and curing agent 
was poured atop the wafer and baked at 85 °C for 50 min. The PDMS was gently 
peeled off the wafer and fluid ports were punched with a 0.75 mm diameter 
biopsy punch (Ted Pella, Inc.). The PDMS microchannel and electrode pattern 
were then exposed to oxygen plasma (Jelight, Model 42A) and immediately 
aligned and sealed under an inverted microscope. As shown in Figure 7.1(a), the 
device consists of a main flow channel 100 μm wide and 65 μm high. The 
embedded electrodes are axially separated by 20 μm and symmetrically bridge the 







utilized in order to maximize the electric field strength across the liquid interface, 
as the sharp point serves to focus the electric field to the tip of the electrode. 
 
7.2.2 Sensor measurement 
 The electrical interface was created using the microfluidic “T- channel”. 
Two fluid streams were introduced into the device via pressure driven flow using 
an externally pressurized cryogenic vial. Shown in Figure 7.2(a), the left-most 
(red) high conductivity stream consists of a 0.5 M phosphate buffered saline, pH 
7.4, (PBS) solution with 10 ng/mL of Alexa Fluor 594 (Invitrogen). The right-
most (purple) high dielectric stream consists of 0.8 M 6-aminohexanoic acid 
(Sigma-Aldrich) (AHA) labeled with 10 ng/mL of Alexa Fluor 647 (Invitrogen). 
AHA is a water-soluble zwitterion used for increasing the dielectric constant of 
aqueous solution. Prior to fluorescent labeling, the AHA solution is spun down in 
a centrifuge for 15 min in 1 g/mL Dowex MR-3 (Sigma) ion exchange resin to 
remove trace salts and reduce solution conductivity
2
. A cross-sectional view of 
the resulting fluid interface was imaged using dual excitation confocal 








Figure 7.2. Confocal displacement micrographs. (a) Confocal micrograph of two fluorescently 
labeled fluids flowing side-by-side to create a liquid interface. Scale bar 50 μm; (b) 3D confocal 
image stack of the electrical interface formed between to fluids with different electrical 
conductivities and dielectric constants. Scale bar 20 μm; (c) the interface enters the electrode array 
and displaces across the flow channel. The direction of this displacement is dependent on the 
frequency of the applied electric field. Scale bar 50 μm; and (d) confocal micrograph illustrates a 
side-view of the interface at different electric field frequencies. Scale bar 20 μm. (For 
interpretation of the references to color in this figure legend, the reader is referred to the web 








 To create the electrical interface two fluid streams, each with a different 
set of electrical properties, are pressure injected into the microfluidic device. An 
AC potential of 10 V peak-to-peak (Vpp) at a frequency of 1 MHz was dropped 
across the electrodes, and slowly is increased to 20 MHz while continuously 
monitoring the displaced position of the fluid interface. 
 
7.2.3 Protein solutions 
 Biotin, avidin, bovine serum albumin, and mouse anti-bovine serum 
albumin were purchased from Sigma Aldrich, USA, and used as received. A 16 
μM biotin solution was made by diluting a 4 mM stock with AHA and labeled 
with 10 ng/ml Alexa Fluor 594, and pH adjusted to 7.4. The avidin solution was 
made by adding powdered avidin to PBS labeled with 10 ng/ml Alexa Fluor 647. 
The conductivity of the PBS solution was adjusted to 0.25 mS/cm using DI water. 
All subsequent solution avidin concentrations were made by serial dilutions with 
a stock dilute PBS. The final avidin con- centration was calculated using a UV 
spectrometer (Thermo Scientific Genesys 10S). 
 
7.2.4 The electrical interface 
 IET biosensors are bioaffinity sensitized electrical liquid inter- faces that 
electrokinetically displace in response to biomolecular binding. They require both 







using a PDMS micro- fluidic T-channel. An AC electric field is generated using 
an array of co-planar gold microelectrodes lithographically patterned onto the 
surface of a glass slide. The PDMS-electrode assembly is aligned under an optical 
microscope and plasma bonded to create a complete electro-fluidic device (Figure 
7.1(a)). The EI is composed of two co-flowing electrolyte streams. Both streams – 
streams 1 (left) and 2 (right) – have finite electrical conductivity and permittivity, 
but one has a greater electrical conductivity and the other a greater electrical 
permittivity such that       and      . Because the streams do not mix 
except by diffusion, a sharp electrical mismatch is created at their co-flowing 
interface, which can be polarized (e.g. charged) and displaced across the 
microchannel using a perpendicular AC electric field. 
 
7.2.5 Measuring interfacial frequency response 
 To quantify displacement, the interface position is imaged using confocal 
microscopy; each stream is labeled with a different fluorescent marker – Alexa 
Fluor 594 (red) or 647 (purple) – and imaged, yielding top-down 2D (Figure 
7.2(a)) and 3D (Figure 7.2(b)) micrographs of the interface and its position within 
the microchannel. When a perpendicular AC electric field is applied, the interface 
displaces across the channel in a direction and magnitude de- pendent on the field 
frequency (ω). This displacement response can be confocal imaged and quantified 







displacement over the length of the electrode array for three different applied 
frequencies: ω = 1 MHz, 9.2 MHz, and 20 MHz. At a frequency of 1MHz (Figure 
7.2(c)-bottom), the interface enters the array and continuously displaces across the 
main flow channel into the high permittivity flow stream. At high frequency (20 
MHz), the displacement direction reverses (Figure 7.2(c)-top). At an intermediate 
crossover frequency (COF) of 9.2 MHz, the interface does not displace in the 
electric field and remains stationary over the entire length of the array (Figure 
7.2(c)-center). 
 The force driving interface motion is a surface force that exists over the 
separation length scale between the electrodes in the array. Because this length 
scale (20 μm) is smaller than the microchannel height (100 μm), field-driven 
displacement is localized to the bottom of the microchannel. Fluid near the top of 
the channel is driven in the opposite direction to satisfy conservation of mass, and 
the interface appears to tilt to the left or right depending on the applied field 
frequency. Figure 7.2(d) shows the side-view of the displaced tilted interface for 
each applied field frequency. 
 In this work, we propose to use the frequency response of the interface as 
a biosensing transducer for detecting biomolecules at a microfluidic liquid 
interface. To accomplish this, we measure the net displacement of the EI as a 
function of applied electric field frequency at the bottom surface of the 







interface calculated from the micrograph experiment presented in Figure 7.2. The 
displacement (∆d) has been rendered non-dimensional over the microchannel 
width, and varies from –1 to 1. At the COF, the interface does not displace: ∆d = 
0. Above and below the COF the displacement is finite and varies in both 
direction and magnitude with the applied frequency. 
 
Figure 7.3 Electrical and reaction influence on displacement and dimensionless frequency. (a) 
Liquid interface polarization [Eq. (1)] plotted as a function of field frequency. Low frequency 
polarization is driven by differences in electrical conductivity, while the interfacial dielectric 
constant governs the polarization of the interface at high frequency. A cross over frequency [Eq. 







increases during biomolecular binding. (b) Dimensionless interface displacement measured at 
different electric field frequencies. An optical micrograph highlights interface position at low (1 
MHz), intermediate (9.2 MHz) and high (20 MHz) field frequencies; (c) optical micrographs of 
the electrical interface captured at different positions and electric field frequencies along the 
length of the electrode array. The interface crossover for each axial position is highlighted in blue 
and plotted in the adjacent figure; and (d) IET sensorgram showing the influence of binding on 
interface crossover frequency plotted against two biosensor negative controls. (For interpretation 
of the references to color in this figure legend, the reader is referred to the web version of this 
article.) 
 
7.2.6 Electrokinetics of an electrical interface-fluidic dielectrophoresis 
 The motion of an electrical liquid interface in an externally applied AC 
electric field is known as fluidic dielectrophoresis (fDEP) 
2
. Despite being 
discovered over six decades ago for particle suspensions
152
, dielectrophoresis has 
only recently been applied to aqueous liquid interfaces. Here, we theoretically 
define the electrical and frequency dependence on the interface displacement, and 
apply this to our IET biosensor measurements. 
 For an EI subjected to a time varying monochromatic AC electric field, 
the magnitude and direction of the interfacial displacement is directly proportional 
to the interface polarization factor: Κ(ω). This factor describes the magnitude and 
sign of the field-induced ionic and dielectric charge that is induced at the EI in 
response to the electric field. Because the field oscillates monochromatically in 
time, the sign and magnitude of charge at the interface is dynamic, and reverses in 
phase with the electric field. This process takes a finite time, and depending on 
the field frequency, not all of the induced charge will be able to dynamically stay 







and imaginary parts, dependent on field frequency, and liquid conductivity and 
permittivity differences across the EI. Displacement is driven by the real part of 
this expression (i.e. interface charging that is in-phase with the applied field). The 
out of phase (imaginary) part produces a net interfacial electric stress with a zero 
time-average and does not contribute to interfacial motion. Therefore, we use the 
real part of the polarization factor in this work. 
 For an electrical interface composed of two co-flowing aqueous 
electrolytes with different electrical conductivities and permittivities, the real part 
of the interfacial polarization factor is 
         
    –   
    
                
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              
   (7.1) 
where  = ( 2+ 1)/( 2+ 1) is the characteristic charge relaxation timescale at the 
interface between the two liquids. 
 Illustrated in Eq. (1), fDEP provides a unique method for quantifying the 
electrical properties of an EI because displacement direction and magnitude are 
both dependent on the relative electrical property mismatch between the 
interface's two co-flowing fluid streams. In Figure 7.3(a), we plot Eq. (1) as a 
function of electric field frequency, and highlight the influence of electrical 
conductivity and permittivity mismatches at high, intermediate, and low AC field 
frequencies. At low frequency below the COF, polarization is driven by 







which we define here as interfacial conductivity (∆σ). Above the COF at high 
frequency, displacement is governed solely by interfacial permittivity (∆ε). The 
COF (ωCOF) occurs where the net polarization and displacement of the interface is 
zero (Figure 7.3(b)). It is sensitive to both interfacial conductivity and 
permittivity, shown here by setting the polarization factor equal to zero 
(Re[K(ω)]=0), and solving for frequency: 
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 Depicted in Figure 7.3(a), interface displacement at low and high 
frequency is influenced only by interfacial conductivity and permittivity, 
respectively, and the COF is a function of both properties. 
 The transducing element of our IET biosensor is based on the interface 
COF. First, because the interface COF is influenced by both EI conductivity and 
permittivity, it is a single frequency measurement capable of monitoring both of 
these properties simultaneously at a liquid interface. Second, because the COF 
occurs when interfacial displacement is zero, it is a simple measurement to 









7.2.7 Using interfacial crossover frequency to detect specific binding 
 To detect specific binding at a liquid interface, the EI is sensitized with 
target probe molecules and forced to flow adjacent to a sample stream containing 
an analyte. With developed and continuous flow down the T-channel, the fluid at 
each axial position within the main channel has a different average residence 
time, and the binding process will be at different time points of diffusive-reactive 
transport. To monitor binding dynamically during this process, the COF at the EI 
is quantified at discrete axial positions down the length of the main flow channel. 
Changes in EI electrical properties during binding influence the COF. Because 
specific binding progresses forward in time as fluid flows down the length of the 
array, biomolecular binding can be electrokinetically quantified in time by 
measuring the COF at varying positions in axial space down the channel length. 
 
7.3 Results and discussion 
 
7.3.1 The IET biosensor sensorgram 
 Our IET biosensor signal was the COF of the liquid interface. We 
performed this measurement at discrete positions over the entire axial length of 
the microelectrode array to detect biomolecular binding dynamically in time. We 
used biotin–avidin as the model system for studying the biosensor response. 







is a useful binding model for characterizing biosensing systems. To more clearly 
compare sensor performance against different concentrations of avidin, both 
experimental variables – the COF and the array position – were rendered 
dimensionless. Shown in Figure 7.3(c), the electrode array was rendered 
dimensionless by its total length (2.0 mm); COF measurements were quantified 
along a dimensionless axial variable x*, spanning the domain {0,1}. To maintain 
consistent reaction residence times within the electrode array, the fluid flow rate 
was fixed at 5.0 μL/min. We performed all min biosensing experiments using 
buffers with constant conductivity and permittivity. Because these properties were 
constant, the COF at x* = 0 was fixed: COFIN = 4.8 MHz ± 1%. To track the 
evolution of the COF over the axial position of the array, the COF was rendered 
dimensionless (ω*) by COFIN such that ω* = 1 at x* = 0. 
 To determine if specific avidin–biotin binding influences the COF of the 
interface, a COF sensorgram was captured using 2.5 μM avidin flowing adjacent 
to 16 μM biotin. We used two negative controls for this experiment – one COF 
sensorgram was taken without biotin, and a second without avidin. Finally, we 
measured the COF sensorgram along the EI within the electrode array with both 
avidin and biotin. Figure 7.3(d) shows the ω* vs. x* sensorgram from each 
experiment. In the absence of binding, the interfacial COF decreases by ~8% over 







COF increases by over 30%, reaching an equilibrium value of ω* = 1.3 at a 
distance x* = 0.4 down the array. 
 The polarized interface behaves as a biosensor transducer; specific binding 
influences the interfacial electrical properties, which are transduced 
electrokinetically as a change in COF for a given position down the electrode 
array. The COF changes dynamically, transducing biomolecular binding events 
over axial length as they proceed forward in time. This concept is reflected in the 
sensorgram data (Figure 7.3(d)), where the COF appears as a binding curve, 
increasing over the array length and plateauing as the re- action saturates at the 
EI. The transduction properties of the EI can be observed optically, as depicted in 
the confocal micrographs shown in Figure 7.3(c). As the field frequency is 
increased, the axial position where no interface displacement occurs shifts. The 
COF at x* = 0.1, for example, is 5.28 MHz; no displacement is observed at this 
point in the array. This frequency is above COFIN (4.8 MHz) at x* = 0 and below 
the COF for any position where x* = 0.1, so the interface deflects in opposing 
directions surrounding this inflection point. As the applied frequency is increased, 
the position of the inflection point shifts, corresponding to a new position-
dependent COF. These COF inflections are highlighted with blue boxes in Figure 
7.3(c). They represent COF measurements for three axial positions within the 
electrode array, and correspond to the sensorgram data points emphasized with 








7.3.2 Avidin–biotin binding influences interfacial conductivity 
 The response of the IET sensor is based on the influence of bioaffinity 
binding on the interfacial electrical properties at the EI. Because the COF is 
sensitive to both interfacial conductivity and permittivity, COF measurements are 
not enough to determine the exact electrical influence that biomolecular binding 
has on the interface. To determine how binding influences the electrical properties 
across the interface, we measured the net displacement during binding over 
varying AC field frequency at the saturation position x* = 0.4 down the electrode 
array. Figure 7.4(a) shows interfacial displacement spectrum as a function of field 
frequency for three different avidin concentrations: 0 nM, 25 nM, and 2.5 μM. 
The electrical mismatch of each of the fluids containing both avidin and biotin 
were held constant for each experiment. As shown above in Figure 7.3(a), low 
frequency displacement is dependent solely on the interfacial conductivity and 
depends only on interfacial permittivity at high frequency. From the spectra 
presented in Figure 7.4(a), avidin–biotin binding influences the low frequency 
displacement measurements – displacement increases with avidin concentration. 
At high frequency, however, interfacial displacement remains constant and is not 
influenced by interfacial binding. Figure 7.4(b) shows a series of confocal 







avidin concentration increases (Figure 7.4(b) – Left), and high frequency (20 
MHz) displacement remains unaffected with binding (Figure 7.4(b) – Right). 
 
Figure 7.4 Effects of biotin-avidin binding on interfacial displacement. (a) Interface displacement 
measured over increasing concentrations of avidin: 0 M, 25 nM, and 2.5 μM. (b) Confocal 
micrographs illustrate interface position at low (1 MHz) and high (20 MHz) for increasing avidin 
concentrations. Scale bar 20 μm. 
 
 The displacement measurements in Figure 7.4 demonstrate that the 
biomolecular binding of avidin–biotin increases the interfacial conductivity (∆d 
increases at low frequency with binding), but not alter the interfacial permittivity 
(∆d remains unaffected at high frequency). While fDEP can give insight as to how 
the interface is being influenced electrically, it cannot currently provide any 
mechanistic information about why this increase is occurring. The increase in 
interfacial conductivity may be due to counterion release during binding. One 
possibility is that a diffuse layer of spatially confined counterions surrounds the 







potentially increase the electrical conductivity in the vicinity of the interface, and 
produce an increase in COF. Another possibility could be due to a change in 
electrophoretic mobility due to the negative charge of the bound biotin molecule, 
which would make the complex a more effective charge carrier at the interface. 
Currently, however, the precise physical mechanism for the interfacial 
conductivity increase remains unknown. 
 









7.3.3 Selective and specific biosensing in a BSA background 
 Surface-based heterogeneous biosensors can suffer from non-specific 
adsorption of background proteins, which can reduce sensor sensitivity. The IET 
sensor utilizes a liquid interface as a biorecognition substrate, and therefore is 
much less prone to suffer from biofouling or non-specific adsorption of proteins 
to the sensor surface. However, background interference from non-specific 
proteins is a major concern when working with real-world clinically relevant 
samples. To investigate sensor performance in the presence of an abundant 
background protein, we challenged the sensor with 5 mg/mL of bovine serum 
albumin (BSA). In order to be able to compare our findings with the avidin–biotin 
experiments performed without a background (Figure 7.3(d)), the inlet COF and 
microchannel flow rate were held to less than a 1% deviation from their previous 
experimental values. Shown in Figure 7.5, the COF increases about 25% over the 
length of the array when taken with 2.5 μM avidin flowing adjacent to 16 μM 
biotin in the presence of a serum background. To investigate the ability to design 
specific bioaffinity response into the EI, we removed avidin from the sample 
stream and replaced it with a 100 nM concentration of anti-BSA. Shown in Figure 
7.5, the sensor responds to the presence of BSA instead of avidin. Two control 
experiments were performed to ensure these measurements were specific – 
removal of anti-BSA and avidin from the sample stream does not produce an 







 There are several important features to note regarding the sensor 
performance depicted in Figure 7.5. First, as shown, when compared to the 
sensorgram without BSA, the selectivity of the sensor towards avidin in the 
presence of serum decreases by 30%. This decrease could be due to several 
factors. There is a possibility that non-specific charge–charge interactions
153
 
between BSA and the surrounding biomolecules in solution could be influencing 
the interfacial conductivity and total concentration of avidin available for binding. 
However, as shown in the BSA sensorgram in Figure 7.5, the addition of 
background avidin to the BSA solution during binding with anti-BSA does not 
affect the magnitude of the sensorgram. This suggests that non- specific 
interactions between BSA and avidin are minimal. 
 Because the sensor COF is driven by a combination of both target–
receptor binding and interfacial smoothening by ionic diffusion, we speculate that 
the addition of BSA hinders the rate of avidin diffusion towards and across the 
interface, which slows the rate of the binding and leads to a lower sensor COF. 
Finally, it is worth noting that the reaction between BSA and anti-BSA does not 
produce the same change in COF when compared to the avidin and biotin 
reaction. We hypothesize this difference is due to the difference in binding 





, for the avidin– biotin and BSA–anti-BSA
154
 reaction, respectively, the 







and biotin. Since the reaction time is slower, binding requires a longer distance 
down the axial length of the microchannel. Because the diffusion of ions across 
the electrical interface is constantly occurring and decreasing the interfacial 
conductivity, the reaction requiring a greater length scale must compete with an 
ever-decreasing interfacial conductivity, which ultimately leads to a smaller 
magnitude in the change of COF. Future work will focus on developing a better 
understanding of these physicochemical mechanisms that link species reaction 










Figure 7.6 IET sensorgrams and binding curves. (a) IET sensorgram of increasing concentrations 
of avidin; (b) sensorgram illustrating sensor response against a background of serum albumin; (c) 
sensor binding curve showing IET limit of detection without a BSA background; and (d) with a 
BSA background. 
 
7.3.4 Label-free femtomolar detection in BSA 
 We next performed a series of experiments to determine the IET sensor's 
limit of detection (LOD) and how the IE performs as a transducer against an 
abundant background protein (5 mg/mL BSA). The IET biosensor response was 
measured as a function of avidin concentration, ranging from 50 fM to 2.5 μM, 







biotin binding at the EI (Figure 7.6(a)) and with a BSA background (Figure 
7.6(b)). The net IET sensor response increases with avidin concentration, and 
eventually levels to a constant value some distance down the electrode array. The 
eventual leveling of the IET signal at a given position down the array length can 
be attributed to the saturation of the interface with bound avidin–biotin complex; 
avidin is depleted from the local EI and the sensor response saturates. 
 The magnitude of each saturated sensorgram response at a fixed distance 
down the electrode array (x* = 0.5) was isolated and plotted as a function of 
avidin concentration. The resulting calibration curve is shown in Figure 7.6(c) for 
an EI without BSA and in Figure 7.6(d) for the interface subjected to a serum 
background. For each analytical curve, the sensor exhibits a linear response with 
increasing concentrations of avidin up to 500 fM, as shown in the subplots of each 
(Figure 7.6(c) & (d)). Beyond this linear concentration range, the sensor deviates 
and begins to level off, eventually saturating at an avidin concentration at 
approximately 1 μM. The concentration LOD was calculated using the 3-sigma 
method (S/N = 3) for each binding curve. Without background BSA, the sensor 
LOD was 209 fM, while the addition of BSA decreased sensor sensitivity with a 









 In this work, we presented a sensitive and selective label-free 
electrokinetic biosensor for detecting biomolecules at electrically polarizable 
liquid interfaces. Biomolecular binding occurs at the diffuse electrical interface 
formed between two co-flowing microfluidic laminar streams with different 
electrical properties. The biosensor approach is based on measuring the electrical 
field-induced displacement frequency response of this interface, which is 
sensitively influenced by specific biomolecular binding. In this manner, the 
biosensor design utilizes this interface as substrate for biomolecular binding, and 
its motion in an electric field as a signal transducer. We have shown that binding 
increases the electrical conductivity at the interface, which is transduced as a 
change in interfacial frequency response, and forms the basis for our presented 
interfacial electrokinetic transduction (IET) method. The system developed can 
detect low femtomolar avidin concentrations against a 5 mg/mL background of 
serum albumin, and can be reconfigured to detect other proteins. The IET sensor 
has the potential be extended to other biomolecular systems for the detection of 
disease biomarkers in serum and urine. Furthermore, because binding occurs 
dynamically in time over the length of the microchannel interface, it should be 
possible to use this IET approach to study the binding kinetics of a variety of 
specific ligand–receptor pairs. Finally, while fluorescent microscopy was used in 







inexpensive methods for measuring interface displacement electrically, extending 
our IET approach to more complex samples such as whole blood and urine, 
reducing interfacial diffusion of the electric interface, and developing reactive 
trans- port models to study binding kinetics at the liquid interface. 
 
 
Reprinted with permission from Biosensors and Bioelectronics
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Nanoparticle-based biosensing using interfacial 
electrokinetic transduction  
 
 
 In this chapter, we present a novel label-free electrokinetic method for 
detecting biomolecular binding on nanoparticles suspended in the vicinity of a 
laminar microfluidic interface. The sensor is based on the deflection of the liquid 
interface in an external AC electric field. Biomolecular binding on particles is 
shown to increase the interfacial electrical conductivity of the suspending 
electrolyte, which is sensitively transduced as a change in electrokinetic 
interfacial deflection. Using this approach, we detect the binding of biotin on 
streptavidin-functionalized nanoparticles at concentrations as low as 500 aM and 
perform detection of human IgG at clinically relevant concentrations (1.25–12 
mg/mL) without labels. The interface response is only influenced by specific 







concentration of reactive particles is reduced. Furthermore, we show that control 
experiments with both non-reactive particles and lack of a specific target analyte 
do not produce interfacial deflection. This work provides a promising method for 
quantifying bead-based binding kinetics for sensitive and specific biosensing in 
solution without labels. 
 
8.1 Introduction  
 The ability to detect biomolecular targets at low concentrations without 
labels is an important requirement in areas including clinical diagnostics, drug 
discovery, environmental monitoring, and biomedical research. To be successful, 
biosensors typically require three basic components – a substrate for specific 
binding to occur, a transducer to translate the binding event into a detectable 
signal, and a detector to measure the transduced signal. Bead-based heterogeneous 
biosensors use nanoparticles with surface-immobilized receptors as a biosensing 
substrate for detecting a wide range of biomolecular analyte targets including 
proteins
3
, DNA, and bacteria
4,5
. In comparison to traditional substrate-based 
microarray technology, the high surface-area-to-volume ratio of functionalized 
nanoparticles can lead to increased detection sensitivity and reduced assay time. 
Bead-based methods, for example, have been shown to increase the limit of 

























 Nanoparticle-based biosensing is often accomplished using a 
heterogeneous support, where particles are adsorbed onto a solid surface
12
 or a 
sol-gel matrix
13
. Nanoparticles functionalized with specific receptors are then 
flushed with a fluid or gas containing the relevant target analyte. Because colloids 
must be functionalized and assembled, current bead-based methods typically 
require multiple rinsing/drying steps
14,15
, can suffer from functional group 
crowding
16
 and surface fouling
17
, and are usually designed for single use. 
 To reduce detection time and assay complexity, and to improve 
portability, biosensors can be integrated with microfluidics. With microfluidics, 
biomolecular binding can occur not only on functionalized solid surfaces, but also 
in solution phase at the interface formed between laminar liquid streams using 
low Reynolds number fluid flow. This sensing strategy is robust and has been 
successfully applied to detecting DNA hybridization
18
 and for protein 
immunoassays
19
. Matthews et al, for example, reported a novel homogenous 
microfluidic biosensor using laminar aqueous interfaces as a biosensing substrate. 
Two co-flowing fluids – one containing a target analyte and a second with 
complimentary receptors – were forced to flow side-by-side along a main flow 
channel. Biomolecular binding occurred as target and receptor molecules diffused 







microscopy, binding kinetics were quantified by measuring fluorescent intensity 




 Laminar liquid interfaces can be created using “T-channel” or “Y-
channel” microfluidic geometries
20,21
. The two fluids produce a quasi-stable liquid 
interface at their co-flowing contact region, where at low Reynolds number mass 
transport across the interface is driven strictly through diffusion
22
. Performing 
biosensing though diffusional mixing and biomolecular binding has several 
advantages over traditional heterogeneous biosensing at solid substrates. First, 
because biomolecular binding occurs in solution phase as opposed to a solid 
surface, diffusion-limited binding occurs over much shorter timescales. Second, 
the interfacial substrate is continually replenished and renewed at any given 
position in the microchannel and is therefore not subject to surface fouling and 
non-specific adsorption.  
 Despite the usefulness and advantages, current liquid interface-based 
microfluidic strategies require fluorescent labeling and fluorescent microscopy for 
signal transduction and detection
23
. Recently, Mavrogiannis et al. reported a novel 
label-free electrical detection strategy using an electrokinetic phenomena known 
as fluidic dielectrophoresis (fDEP). In fDEP, alternating current (AC) electric 
fields are used to polarize and electrically stress a liquid interface. The interface is 







conductivity and dielectric constant than the adjacent stream. When an electric 
field is applied, charges accumulate and force the interface to deflect across a 
microfluidic channel. The magnitude and direction of this deflection is sensitive 
to the interfacial electrical properties
2
. Exploiting this phenomena, Mavrogiannis 
et al. demonstrated that interfacial biomolecular binding influences the liquid 
electrical conductivity and polarizability of the liquid interface, and that binding 
can be detected by quantifying the degree of interfacial deflection at varying 
positions down the microchannel
24
. In this way, binding is transduced as a change 
in the interfacial deflection of the fluid interface, which can be imaged and 
detected optically or electrically without labels.  
 Biomolecular detection using fDEP has been termed interfacial 
electrokinetic transduction (IET)
24
. In this method, the displacement of the 
interface is measured to detect biotin-streptavidin binding. This approach has 
been used to detect model avidin:biotin biomolecular binding at avidin 
concentrations as low as 50 femtomolar (fM), enabling it to compete with 
methods like surface plasmon resonance (SPR) (3 nm to 1.5 fM)
156
 and enzyme-
linked immunosorbent assays (ELISAs) (100 fM and below)
157
, which are the 
current standard of clinical sensitivity. 
 In this work, we extend the usefulness of IET to that of nanoparticle bead-
based assays and show that biomolecular binding on nanoscale particles can 







investigate the ability to detect biomolecular binding on the surface of 
functionalized colloids subjected to specific biomolecular binding events 
suspended in solution in the vicinity of a liquid interface. The nanoparticles are 
functionalized with streptavidin molecules, which serve as specific binding 
receptors for biotin in solution. We demonstrate that specific binding on the 
nanoparticles produces a change in the electrical conductivity across the liquid 
interface, which is detected by IET. This colloid-based biosensing strategy does 
not use labels, amplified signaling, or methods for concentrating the analyte 
samples and is capable of detecting binding for biotin concentrations as low as 
500 aM. 
 
8.2. Material and Methods 
 
8.2.1 Device Fabrication 
 In this section we describe the methods to fabricate the experimental 
devices and describe a theoretical basis for the biosensing measurements. The 
biosensing device used in this work requires a combination of microfluidic flow, 
electrokinetics, and colloid-based biomolecular surface chemistry. We utilize a 
microfluidic T-channel device to create a liquid interface through forcing fluid 
streams to flow side-by-side. One fluid phase contains a suspension of 







To deliver an electric field across the interface, we integrate an array of 
microelectrodes within the main flow channel. The complete device, illustrated in 
Figure 8.1, is fabricated using a combination of microfluidic soft lithography and 
wet etching techniques. To fabricate the microarray of electrodes, we first coat 
glass cover slides (50x30 mm, no. 1, Fisher Scientific) with a 20 nm layer of 
chromium, followed by a 30 nm layer of gold, using electron beam deposition. 
Positive photoresist (S1813, Shipley) is spun onto the gold-coated slides and 
exposed using a UV contact aligner with a positive mask (Fineline Imaging) 
before etching the gold and chrome layers with chemical etchants (Alfa Aesar). 
The resulting electrodes are aligned symmetrically across the main flow channel 
axis, and spaced at 20 m intervals, with pointed tips to focus the electric field at 
the liquid interface (Figure 8.1(b)). To fabricate the microchannel, we create a T-
channel master mold by spin-coating negative photoresist (SU-8 3050, 
Microchem Corp.) on a 4-inch silicon wafer (Silicon Inc.) and exposing to a UV 
light source through a negative mask. The microfluidic channels are created by 
pouring PDMS, mixed in a 10:1 elastomer-to-curing-agent ratio, over the wafer 
mold and cured at 85 °C for 30 minutes. The cured polymer is peeled off and cut 
to size; fluid ports are created with a 0.75 mm biopsy punch (Ted Pella, Inc.). 
Finally, PDMS is bonded to the glass slide by exposure to oxygen plasma (Model 
42A, Jetlight) for 1 minute, and immediately aligned and sealed by eye under an 







connected to a main microfluidic channel measuring 100 m across and 35 m 
high (Figure 8.1(b)).  
 
Figure 8.1. Microfluidic T-Channel. (a) Schematic of the microfluidic T-channel device with two 
co-flowing fluorescently labelled fluids. Scale bar 100 m. (c) 3D confocal with integrated 
electrodes. (b) Top-down confocal micrograph of the T-channel device z-stack of the microfluidic-
generated electrical liquid interface. Scale bar 50 m.  
 
8.2.2 Creating the Electrical Liquid Interface 
 Fluid flow is driven into the device using an external pressure source at a 
constant flow rate of 5 L/min. To create the electrical properties necessary for 
fDEP, one fluid stream consists of a 10x diluted phosphate buffered saline (PBS) 
solution and the adjacent stream contains a 0.8 M solution of 6-aminohexanoic 
acid (AHA) (Sigma Aldrich). AHA is a water-soluble zwitterion intended to 
increase the dielectric constant of the aqueous solution
158
. To create a biosensing 
system at the liquid interface, we integrated a biomolecular recognition event 
between the two fluids, where one stream contained a suspension of 
functionalized nanoparticles, and the adjacent phase was used as a stream 







streptavidin-coated nanoparticles as a model biomolecular system to test our 
particle-based sensing strategy. Biotin (Sigma Aldrich) and 100 nm streptavidin-
coated silica nanospheres ( = -34.6 mV) (Corpuscular Inc.) were used as the 
model bioreaction for this system; 100 nm carboxylated silica nanospheres ( = -
34.3 mV) (Corpuscular Inc.) were used as a non-reactive negative control. A 
4mM biotin stock solution was made in 0.8 M AHA and subsequently diluted to 
experimental concentrations ranging between 500 aM and 16 M. The PBS 
stream contained the nanoparticle substrate: streptavidin-coated particles were 
triple washed and re-suspended in PBS solution and particle suspensions were 
maintained at 0.0375 wt% for all experiments unless specified otherwise. Human 
immunoglobulin G (IgG) (Sigma Aldrich) and 350 nm protein-A-coated silica 
nanospheres (Corpuscular Inc.) served as the physiologically relevant reaction 
scheme. Human IgG was dissolved in deionized water at a concentration of 5 
mg/mL and diluted to experimental concentrations. Finally, the resulting fluid 
interface was imaged using confocal microscopy. The fluid stream containing 
AHA (with or without biotin) was fluorescently labeled “red” with 10 ng/mL 
Alexa Fluor 594 and the adjacent PBS stream (containing either streptavidin or 









Figure 8.2. fDEP Crossover Frequency. (a) Top-down confocal images of the microfluidic 
channel, showing interfacial displacement for frequencies below the crossover, (b) at the 
crossover, (c) above the crossover. Scale bar 25 µm. (d) 3D confocal images showing the tilt of 
the electrical interface for frequencies below the crossover (left), at the crossover (center), and 
above the crossover (right). Scale bar 50 µm. (e) Crossover frequency plotted as a function of 
conductivity difference. The MW Theory line is plotted as Equation (3) for fixed values of ε1 = 
78.2 & ε2 = 110. Lettered boxes are selected from the 0.0375 wt% data. (f) Displacement of the 
electrical interface as a function of applied frequency. Each complete dataset’s COF is highlighted 








8.2.3 Fluidic Dielectrophoresis 
 When each fluid phase is driven into the main microchannel, the resulting 
liquid interface has a steep gradient in the electrical properties between each fluid 
phase. The PBS stream has a high relative conductivity and a low permittivity (  
= 0.35 mS/cm,   = 78.2), while the AHA stream has a low electrical conductivity 
but a high permittivity (  = 32 S/cm,   = 110). When an AC electric field is 
applied across the interface at a potential of 10 volts peak-to-peak (Vpp), the 
electrical mismatch drives an electric field-driven charge accumulation at the fluid 
interface, which leads to an electrical stress and a physical electrohydrodynamic 
displacement of the fluid interface that is visually observable. This phenomenon is 
depicted at different AC electric frequencies in Figure 8.2(a)&(b). Because it 
takes a finite amount of time for the interface to polarize and displace from its 
original position, the sign and magnitude of the interfacial stress is sensitive to the 
AC frequency of the electric field. At low AC field frequency, for example, the 
high conductive PBS stream displaces into the less conductive AHA stream, as 
the field oscillates slowly enough for mobile ions in solution to electromigrate to 
the interface (Figures 2(a)&(b)). At higher frequency, however, polarization by 
ionic conduction does not have enough time to occur, and dielectric polarization 
dominates the interfacial charging. When this occurs, the direction of the 
displacement reverses, and the high-dielectric stream displaces across the channel 







interface such that one phase has a greater electrical conductivity and the other a 
greater dielectric constant, the direction and magnitude of the interfacial 
displacement is highly sensitive to the value of the AC frequency applied. We use 
this behavior as a means to assess whether biomolecular binding has occurred at 
the interface. This frequency dependence can be adequately described using 
Maxwell-Wager polarization mechanics and used to derive the frequency-
dependent expression for the interfacial fDEP force
2
, given by  
                            
 .   (8.1) 
The frequency at which the two charging mechanisms – conductive and dielectric 
– are balanced, (e.g. where FDEP = 0) and no displacement occurs, is referred to as 
the crossover frequency (COF), which is sensitive to any electrical perturbations 
at the liquid interface (Figures 2(a)&(b)). If a biomolecular reaction occurs at the 
interface, for example, the COF will change if the reaction alters the electrical 
properties of the system; this modification becomes magnified as the reaction 
propagates downstream. As such, this electrical change over time can be reflected 
as a change in COF at varying axial positions within the main flow channel which 
can be equated to a different time step in the binding reaction. Therefore, we 
detect binding by inducing specific biomolecular reactions on functionalized 
nanoparticles suspended at the liquid interface, monitor the resulting liquid COF 







deviation from the original COF to determine the presence of a specific 
biomolecular binding event. 
 
8.3 Results and Discussion 
 
8.3.1 Maxwell-Wagner Polarization 
 In this work, we demonstrate that biomolecular binding on colloidal 
particles in suspension can influence the electrical polarization and motion of a 
surrounding laminar liquid interface. This polarization factor satisfies the 
charging mechanics described by classical Maxwell-Wagner polarization 
theory
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, and can be shown as 
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   (8.2) 
Re[K( )] is the real (in phase) component of the Clausius–Mossotti factor which 
describes the degree to which the interface has polarized as a function of electric 
field frequency and  = ( 2+ 1)/( 2+ 1) is the charge relaxation timescale of the 
electrical liquid interface, which is related to the time required for mobile ions to 
electromigrate to the interface. The interfacial COF occurs when the net charge at 
the interface is zero, and is determined by setting Re[K(ω)] = 0, 
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Equation 8.3 can be used to determine the COF for the interface as a function of 
the fluid electrical properties. Plotted as a function of the fabricated electrical 
mismatch in properties (Figure 8.2(c)), we observe that there is a linear 
relationship between electrical conductivity difference across the fluid interface 
and the COF.  
 In this work, we utilize a dilute suspension of colloids instead of a pure 
electrolyte. In order to determine if the existing MW polarization theory is 
appropriate for the case of a dilute colloidal suspension, we first performed 
experiments to determine the interfacial COF as a function of electrolyte 
conductivity using a dilute colloidal suspension of 100 nm carboxylated silica 
particles in PBS buffer.  The resulting COF data is plotted against our theoretical 
model (Equation 8.3) in Figure 8.2(c) for varying concentrations of colloid weight 
percent. The data show good agreement with the MW theory for both the pure 
liquid-liquid and liquid-colloid experiments. From Figure 8.2(c), we therefore 
assume that the colloidal suspensions used in this work are dilute enough to be 
mathematically and electrically approximated as a pure fluid, and that the 
presence of particles does not require additional modifications to our existing 
polarization model. We next measured the net displacement of the interface at 
different electric field frequencies and interfacial electrical conductivities. To 
accomplish this, we adjusted the conductivity of the colloidal suspension while 







8.2(d) we plot the experimental displacement of three different interfacial 
conductivities. The varying interfacial conductivities are labeled a to c, and 
correspond to three COF data points in Figure 8.2(c) highlighted in boxes. The 
data demonstrates that at low frequency the magnitude of the interfacial 
displacement increases with increasing conductive difference across the two 
fluids. However, at high frequency the magnitude of the displacement is not 
affected by conductive differences, because this frequency range is only 
influenced by the dielectric differences between the two fluids.  
 Based on these COF and interfacial displacement results, we demonstrate 
how this interfacial motion can be used as a transducing element for our colloidal 
biosensor. To detect specific binding at the electrical interface, one fluid stream 
containing the target-probe is driven against an adjacent stream containing the 
analyte of interest. During binding on the nanoparticles, changes in the electrical 
properties at the interface due to this biorecognition event will lead to measurable 
changes in the interface COF.  
 
8.3.2 Biotin-Streptavidin Binding 
 As mentioned previously, to determine if the electrical interface acts as a 
suitable substrate and transducer, a well-explored model reaction – biotin and 
streptavidin – was used. The biomolecular reaction between biotin and 











and therefore the reaction is rapid, nonreversible and serves as a good model 
system to demonstrate our biosensing strategy. It is advantageous to incorporate 
nanoparticles into the fDEP biosensor not only for their increased reactive surface 







, the streptavidin-coated silica provides a well-defined 
region of active binding sites at the liquid-liquid interface for biotin, a smaller, 
quickly-diffusing molecule, to rapidly diffuse towards the nanocolloidal interface 
and bind. We first supply biotin in excess (16 M) to provide a constantly 
replenished source of analyte. We first measure the COF at the inlet, which we 
denote as COFin, taking subsequent COF measurements down the electrode array. 
Upon binding, the biotin-streptavidin complex is observed to produce an increase 
in the interfacial COF. This is shown in Figure 8.3, where the COF increases 
down the axial length of the channel, corresponding to product propagation, 
before reaching a plateau, which we believe is indicative of binding saturation in 








Figure 8.3. IET Bead-Based Biosensing Assay. (a) A schematic illustration of the case where no 
reaction is present. Down the length of the channel, the crossover decreases. (b) In the case of a 
biomolecular reaction, the crossover increases as the reaction propagates down the channel. (c) 
Detection sensorgram showing positive detection in the presence of a reaction, with decreasing 
control signals. (d) Limit of detection sensorgram showing the lowest biotin concentration 
detected with the colloid-assisted platform. 
 
 As one type of negative control, we performed the same experiment 
without biotin in the AHA stream. We observed that the COF does not increase, 
but rather it decreases over the axial channel length (Figure 8.3(a)). We attribute 
this decrease to diffusional blending downstream, which smoothens the interface 
and gradually reduces the initially sharp differences in electrical properties across 
the interface, leading to a reduced COF. As a second non-reactive negative 
control, we replaced the 100 nm streptavidin-coated silica nanospheres with 
carboxylated silica beads of the same size and tested the interface response 







groups (-COOH) are meant to emulate the nanocolloidal interface, while 
providing a non-reactive surface to observe any false positive signal from non-
specific adsorption. Similar to the first negative control experiment, the COF 
decreased (Figure 8.3(a)). 
 
8.3.3 Limit of Detection 
 To test the limit of detection for this biosensing strategy, the same 
experiments were performed over decreasing concentrations of biotin ranging 
between 16 M and 500 aM (Figure 8.3(b)). Samples with several order-of-
magnitude decreases in biotin concentration were used and introduced against 
streptavidin-coated beads. The biosensor response, as determined by the interface 
COF, was observed to increase with increasing concentrations of biotin (Figure 
8.3). Using the 3-sigma method, we determined the experimental LOD for biotin 
to be 500 aM. Given the dimensions of the microfluidic device (100 m main 
channel width x 35 m channel height) and a total internal volume of 60 nL, this 
concentration translates to approximately 36 molecules of biotin in the device at 








Figure 8.4. Streptavidin Limited Detection by Varying Particle wt%. Sensorgram illustrating the 
decrease in signal with decreasing weight percent of streptavidin-coated particles. 
 
 We perform another LOD experiment, this time limiting streptavidin. We 







available streptavidin, we reduce the signal response (Figure 8.4). In this 
experiment, we have also decrease the conductivity of the highly conductive 
stream from 0.35 mS/cm to 0.24 mS/cm. The conductivity of this stream is still 
much greater than its neighbor, but the conductivity difference has been slightly 
reduced. It is interesting to note that by reducing the conductivity of the highly 
conductive stream, we increase the contribution of the reaction’s response relative 
to the conductivity difference, and thus increase the magnitude of the signal 
response. The difference can be seen when comparing the saturated case from 
Figure 8.3, where the maximum signal response is 1.09, to the case in Figure 8.4, 
where the maximum response for the saturated case has increased to 1.19. We can 
conclude from this that decreasing the conductivity difference even further could 
bring the limit of detection down below its current 500 aM. 
 
8.3.4 Background Protein 
 To test the robustness and selectivity of the biosensor, we then introduced 
a background of 5 mg/ml bovine serum albumin (BSA) to the biotin stream. We 
observed that the addition of BSA to the system dampens the COF signal, and 
while the COF of the 500 aM case does not increase significantly, it does not 
display the dramatic and immediate decrease in COF as the case of the BSA 








Figure 8.5. Biotin Detection in BSA Background. Sensorgram illustrating the ability of the fDEP 
biosensor to detect biotin-streptavidin binding in a background of 5 mg/mL BSA. 
 
8.3.5 Human IgG-Protein A 
 In moving toward detection of physiologically relevant targets, we test the 
presence of human IgG in solution against 350 nm silica nanoparticles coated 
with protein A. The affinity of protein A binding to human IgG is reported to be 




, five orders of magnitude weaker than biotin-
streptavidin binding. In Figure 8.6, we find a positive response for concentrations 











Figure 8.6. Detection of Human IgG-Protein A Binding. Detection sensorgram showing positive 
detection of human IgG with 350 nm silica nanoparticles coated with protein A. 
 
 We next performed a series of experiments to understand why 
biomolecular binding increases the interface COF. In previous work, 
Mavrogiannis et al. demonstrated that biomolecular binding in solution without 
particles produces a local increase in electrical conductivity difference across the 
liquid interface.
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the interfacial deflection for different analyte concentrations during binding and 
showed that increased analyte concentration only produced a measurable change 
in the interfacial displacement at low field frequency and motion at high 
frequency above the COF was not influenced by binding. 
 To determine what electrical properties were influence through binding, 
we measured the magnitude of interfacial deflection at varying voltage (1-20 
Vpp) and frequencies both below (500 kHz) and above (40 MHz) the COF for 
systems with and without a nanoparticle-based biomolecular reaction. In the 
presence of a reaction, we observe that low frequency interfacial displacement is 
affected by binding, while there is no difference observed at high frequency above 
the COF (Figure 8.6). Based on these experiments, we believe that biotin binding 
on streptavidin nanoparticles increases the local electrical conductivity difference 
across the liquid interface. This is demonstrated in our deflection experiments as 
an increase in interfacial displacement at low frequency, and exploited as a 








Figure 8.6. Influence of binding reaction on electrical properties measured by interface 
displacement. Displacement of the electrical interface versus applied voltage squared for both the 
low and high frequency case, in the case of a biomolecular reaction and a negative control. The 
divergence of the low frequency data suggests that the presence of a reaction alters the local 
conductivity at the electrical interface. 
 
8.4 Conclusions 
 We have shown successful label-free detection of a biotin:streptavidin 
binding on nanoparticles using a colloid-based fDEP biosensor. We were able to 
effectively detect biotin-streptavidin binding at concentrations as low as 500 aM, 







reaction drives a local increase in the electrical conductivity difference across the 
fluid interface. The addition of nanoparticles to the system increased the 
sensitivity by two orders of magnitude when compared to previous work 
conducted using only two liquid phases. The theoretical polarization model 
accurately predicts the experimental COF data, and demonstrates the ability to 
engineer a desired interfacial COF response by simple doping each fluid with 
specific differences in electrical conductivity and dielectric constant. Future 
experiments will involve developing this biosensing strategy into a system for 
testing analytes in physiologically relevant samples. Beads can very easily be 
functionalized with the relevant receptors to detect malaria, various cancers, and 
for other diagnostic exams that require femtomolar detection capabilities. The 
fDEP biosensor can also be used to monitor and study specific time points in a 
reaction at different points down the channel length, given the nature of the 
microfluidic flow device. Finally, future work will incorporate impedance 
spectroscopy to measure interfacial deflection where the fDEP biosensor becomes 
both label-free and non-optical. Removing this current limitation will allow this 
diagnostic device to become completely portable and inexpensive while still being 
highly sensitive and requiring very little sample volume, making it ideal for 























 In the introduction, we presented several problems requiring investigation, 
particularly in the realm of autologous blood doping. While this thesis does not 
represent or provide all the work and components required to fully realize the 
challenges addressed in the body of work, invaluable progress has been made 
toward our research goals.  
 In Chapter 4, we explored the possibility of dielectrophoresis (DEP) as an 
assay for implementation into the Athlete Biological Passport as a direct test for 
autologous blood doping. During the course of this project, we learned that 
storage volumes of blood sample aliquots plays a role in the overall red blood cell 
aging process. We can correct for this by taking larger (~1mL) blood samples, but 
will not investigate further into this phenomenon. We confirmed our assumption 
that in vitro, simulated reinfusions are not representative of the more complex 
nature of a real, in vivo reinfusions. We were surprised to find that while 
separation of the reinfused population grew increasingly difficult in the move 







easier; our results reaffirm the need to investigate further into in vivo autologous 
transfusions. 
 In Chapter 5, we proposed a method to detect autologous transfusions with 
increased throughput. With increased throughput and larger sample sizes, sporting 
entities can achieve greater confidence in results without false positives. Unlike 
the DEP assay in Chapter 4, the RTDC assay was not hindered by the issue that 
arose with storing small whole blood volumes and was able to identify the 
reinfused subpopulation in vitro. Due to the glutaraldehyde-fixed condition of the 
blood doped samples received from our collaborators, the RTDC assay has not yet 
been used to detect in vivo autologous transfusions, which is the next step for this 
platform. After in vivo detection is established, implementation of the DEP and 
RTDC assays into the Athlete Biological Passport require only that these assays 
be automated and troubleshot. 
 In Chapter 8, we presented enhanced detection capabilities over Chapter 7, 
by the addition of a colloidal suspension functionalized with receptors for the 
analyte of interest. This bead-based biosensor is currently being utilized in the lab 
to run biologically relevant detection assays in unadulterated serum and whole 
blood samples. With the addition of impedance spectroscopy, also ongoing in the 
lab, this platform is making large steps toward becoming a sensitive, inexpensive, 
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 Working at the interface of microfluidics and electrokinetics. Engineering 
micro-scale fluidic systems with integrated micro-electrodes with an 
interdisciplinary approach. Utilized analytical skills and creative problem 
solving to break down large research goals, design requisite experiments, and 
appropriately interpret results. 
 







 Decontamination of Chemical Warfare Agents – Defense Threat Reduction 
Agency (DTRA)                 2010 – 2012 
 Designed and implemented an ultra high vacuum testing chamber for 
uptake and reactivity studies on Army vehicle surfaces. 
 Paint surface analysis using SEM, FTIR, and XRD. Funded by Defense 
Threat Reduction Agency (DTRA)  
 3M adhesive polymer blending for breathable adhesive bandages. Blended 
polymers and performed mechanical strength tests on fabricated block 
copolymer films.            2009 
 
Select Publications 
1. Crivellari, F., Mavrogiannis, N., Gagnon, Z. “Nanoparticle-based biosensing 
using interfacial electrokinetic transduction.” Sensors and Actuators B: Chemical 
(2017). 
2. Mavrogiannis, N., Ibo, M., Fu, X., Crivellari, F., Gagnon, Z. “Microfluidics 
made easy: A robust low-cost constant pressure flow controller for engineers and 
cell biologists.” Biomicrofluidics (2016). 
3. Mavrogiannis, N., Crivellari, F., Gagnon, Z. “Label-free biomolecular detection 
at electrically displaced liquid interfaces using interfacial electrokinetic 
transduction (IET)” Biosensors and Bioelectronics (2016). 
4. Baker, J., Crivellari, F., Gagnon, Z., Betenbaugh, M. “Microfluidic bubbler 
facilitates near complete mass transfer for sustainable multiphase and microbial 
processing” Biotechnology and Bioengineering (2016). 
 
Presentations 
1. American Institute of Chemical Engineers Annual Meeting. San Francisco, CA 
– “Detecting Autologous Blood Transfusions Using Dielectrophoretic 
Spectroscopy” Oral                         Nov 2016  
2. Dielectrophoresis Meeting. MIT, Cambridge, MA – “Label-Free Biosensing at 
Polarizable Liquid Interfaces Using Fluidic Dielectrophoresis.” Oral        July 
2016 
3. International Conference on Nanotechnology and Biosensors. Prague, Czech 
Republic – “Colloid-Based Attomolar Detection by Fluidic Dielectrophoresis.” 







4. SciX Conference. Reno, NV – “Colloid-based Biodetection by Fluidic 
Dielectrophoresis.” Oral                          Oct 
2014 
 
Activities & Outreach 
1. Teaching Assistant – Johns Hopkins University. Transport Phenomena II. 
Wrote homework and exam solutions in addition to teaching recitations and class 
lectures during professor absences.              Fall semesters 
2016/2014/2013 
2. Undergraduate Student Mentor – Johns Hopkins University.      2014 – 2017 
3. Women in Science and Engineering (WISE) Mentor – Johns Hopkins 
University.                   2014 
– 2016  
4. Social Chair, Graduate Student Liaison Committee – Johns Hopkins 
University. Hosted and organized social events for the graduate ChemBE students 
to facilitate camaraderie within the department.               
2013 – 2015  
5. Annual Science and Technology Academy Program – Benjamin Stoddert 
Middle School, Marlow Heights, MD. Led students through fundamental lectures 
and hands-on experiments                      
July 2013 
6. Resident Advisor – Virginia Tech. Hypatia Engineering Residental Learning 
Community.                  2009 – 2012 
 
